<SEC-DOCUMENT>0001564590-21-001001.txt : 20210112
<SEC-HEADER>0001564590-21-001001.hdr.sgml : 20210112
<ACCEPTANCE-DATETIME>20210112162401
ACCESSION NUMBER:		0001564590-21-001001
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20210109
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210112
DATE AS OF CHANGE:		20210112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		21523768

	BUSINESS ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 900
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2100 POWELL STREET
		STREET 2:		SUITE 900
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dvax-8k_20210109.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-01-12T18:10:07.2992593+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 77afbd2c82744bb680956a8b0d266e86 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dvax="http://www.dynavax.com/20210109" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
dvax-8k_20210109.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001029142_20210109_20210109">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001029142_20210109_20210109">0001029142</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="dvax-20210109.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001029142_20210109_20210109">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001029142</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-01-09</xbrli:startDate>
					<xbrli:endDate>2021-01-09</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>

<p style="border-top:Solid 0.75pt #000000;padding-top:0pt;text-align:center;margin-top:1pt;line-height:1pt;margin-bottom:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:0pt;text-align:center;border-top:Solid 1pt;padding-top:1pt;margin-bottom:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION<span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549<span style="font-weight:normal;"> </span></p>
<p style="margin-top:5pt;text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Form <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001029142_20210109_20210109">8-K</ix:nonNumeric> </p>
<p style="margin-top:5pt;text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:14pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT<span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section 13 or 15(d) of the</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities Exchange Act of 1934</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): &#160;&#160;<ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001029142_20210109_20210109" format="ixt:datemonthdayyearen">January 9, 2021</ix:nonNumeric> </p>
<p style="margin-top:5pt;text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001029142_20210109_20210109">Dynavax Technologies Corporation</ix:nonNumeric><span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)<span style="font-weight:normal;"> </span></p>
<p style="margin-top:5pt;text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;line-height:4pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Commission File Number:&#160;&#160;<ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0001029142_20210109_20210109">001-34207</ix:nonNumeric><span style="font-weight:normal;"> </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001029142_20210109_20210109" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><span style="font-weight:normal;"> </span></p></td>
<td valign="bottom" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; </p></td>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001029142_20210109_20210109">33-0728374</ix:nonNumeric> <span style="font-weight:normal;"> </span></p></td>
</tr>
<tr>
<td valign="top" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of<span style="font-weight:normal;"> </span>incorporation)</p></td>
<td valign="bottom" style="width:2%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; </p></td>
<td valign="bottom" style="width:49%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer<span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0001029142_20210109_20210109">2100 Powell Street</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0001029142_20210109_20210109">Suite 900</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0001029142_20210109_20210109">Emeryville</ix:nonNumeric>, <ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0001029142_20210109_20210109">CA</ix:nonNumeric> <ix:nonNumeric id="F_000013" name="dei:EntityAddressPostalZipCode" contextRef="C_0001029142_20210109_20210109">94608</ix:nonNumeric><span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, including zip code)<span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:CityAreaCode" contextRef="C_0001029142_20210109_20210109">(510)</ix:nonNumeric> <ix:nonNumeric id="F_000015" name="dei:LocalPhoneNumber" contextRef="C_0001029142_20210109_20210109">848-5100</ix:nonNumeric><span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, including area code)<span style="font-weight:normal;"> </span></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)<span style="font-weight:normal;"> </span></p>
<p style="text-align:center;border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;line-height:4pt;margin-top:0pt;margin-left:40%;margin-right:40%;text-indent:0%;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:4%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000016" name="dei:WrittenCommunications" contextRef="C_0001029142_20210109_20210109" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:SolicitingMaterial" contextRef="C_0001029142_20210109_20210109" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:PreCommencementTenderOffer" contextRef="C_0001029142_20210109_20210109" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td>
</tr>
<tr>
<td valign="top" style="width:4%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Segoe UI Symbol;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001029142_20210109_20210109" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top" style="width:96%;">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="text-align:center;margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act:</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:84.8%;">
<tr style="height:12.65pt;">
<td valign="top" style="width:31.32%;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Title of each class:</p></td>
<td valign="top" style="width:23.14%;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Trading symbol(s):</p></td>
<td valign="top" style="width:45.54%;">
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered:</p></td>
</tr>
<tr style="height:16.6pt;">
<td valign="top" style="width:31.32%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:Security12bTitle" contextRef="C_0001029142_20210109_20210109">Common Stock, $0.001 par value</ix:nonNumeric></p></td>
<td valign="top" style="width:23.14%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:TradingSymbol" contextRef="C_0001029142_20210109_20210109">DVAX</ix:nonNumeric></p></td>
<td valign="top" style="width:45.54%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:SecurityExchangeName" contextRef="C_0001029142_20210109_20210109" format="ixt-sec:exchnameen">The Nasdaq Stock Market&#160;LLC</ix:nonNumeric> </p></td>
</tr>
</table></div>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001029142_20210109_20210109" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;letter-spacing:-0.1pt;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:Segoe UI Symbol;">&#9744;</span></p>
<p style="margin-top:8pt;border-top:Solid 0.75pt #000000;padding-top:0pt;text-align:center;line-height:1pt;margin-bottom:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;border-top:Solid 1pt;padding-top:1pt;margin-top:1pt;line-height:1pt;margin-bottom:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Item 5.02.&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers&#59; Election of Directors&#59; Appointment of Certain Officers&#59; Compensatory Arrangements of Certain Officers<span style="font-weight:normal;"> </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 9, 2021, Dynavax Technologies Corporation (the &#8220;Company&#8221;) adopted the Dynavax Technologies Corporation 2021 Inducement Award Plan (the &#8220;Inducement Plan&#8221;), pursuant to which the Company reserved 1,500,000 shares of its common stock for issuance under the Inducement Plan to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, as an inducement material to the individual&#8217;s entry into employment with the Company within the meaning of Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was approved by the Compensation Committee of the Board of Directors of the Company without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4).</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The foregoing description of the terms of the Inducement Plan is not intended to be complete and is qualified in its entirety by reference to the Inducement Plan and the forms of award agreements adopted under the Inducement Plan, copies of which are included hereto as Exhibit 10.1 and incorporated herein by reference.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits<span style="font-weight:normal;"> </span></p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits. The following exhibit is furnished herewith: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:91%;">
<tr>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td style="width:5.17%;"></td>
<td style="width:77.76%;"></td>
<td style="width:3.07%;"></td>
</tr>
<tr>
<td colspan="3" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160; <span style="text-decoration:underline;">Number</span></p></td>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Description</span></p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1</p></td>
<td colspan="3" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="dvax-ex101_6.htm"><span style="text-decoration:underline;">Dynavax Technologies Corporation 2021 Inducement Award Plan, Form of Stock Option Grant Notice, Option Agreement, Form of Restricted Stock Grant Notice and Restricted Stock Unit Award Agreement</span></a><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p></td>
</tr>
<tr>
<td valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td colspan="3" valign="top">
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES<span style="font-weight:normal;"> </span></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:46.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160; </p></td>
<td valign="bottom" style="width:7.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:5.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="width:3.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:36.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation </p></td>
</tr>
<tr>
<td valign="bottom" style="width:46.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: January 12, 2021</p></td>
<td valign="bottom" style="width:7.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:5.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:3.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:36.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ &#160;STEVEN N. GERSTEN<span style="color:#000000;"> </span></p></td>
</tr>
<tr>
<td valign="middle" style="width:46.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:7.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:5.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:3.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:36.24%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Steven N. Gersten</p></td>
</tr>
<tr>
<td valign="middle" style="width:46.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:7.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:5.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="width:3.16%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:0.6%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:36.24%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Vice President </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dvax-ex101_6.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
dvax-ex101_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 10.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">2021 <font style="font-family:Times New Roman;">Inducement Award</font> Plan</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:18pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Adopted by the Compensation Committee<font style="font-family:Times New Roman Bold;">: January 9, 2021</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447064"></a><font style="Background-color:#auto;text-decoration:none;">1.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">General.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447068"></a><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Eligible Award Recipients.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Awards may only be granted to Employees who satisfy the standards for inducement grants under Rule 5635(c)(4) of the Nasdaq Listing Rules.&nbsp;&nbsp;A person who previously served as an Employee or Director will not be eligible to receive Awards, other than following a bona fide period of non-employment.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M7"></a><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Available Awards.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Plan provides for the grant of the following types of Awards: (i) Nonstatutory Stock Options; (ii) Stock Appreciation Rights; (iii) Restricted Stock Awards; (iv) Restricted Stock Unit Awards; (v) Performance Stock Awards; and (vi) Other Stock Awards.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M8"></a><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Purpose.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Plan, through the granting of Awards, is intended to help the Company and any Affiliate secure and retain the services of eligible award recipients, provide an inducement material for such persons to enter into employment with the Company or an Affiliate within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and provide a means by which such persons may benefit from increases in value of the Common Stock.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447603"></a><font style="Background-color:#auto;text-decoration:none;">2.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Administration.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Administration by Board.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Board will administer the Plan.&nbsp;&nbsp;The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section 2(c).&nbsp;&nbsp;However, notwithstanding the foregoing or anything in the Plan to the contrary, the grant of Awards will be approved by the Company&#8217;s independent compensation committee or a majority of the Company&#8217;s independent directors (as defined in Rule 5605(a)(2) of the Nasdaq Listing Rules) in order to comply with the exemption from the stockholder approval requirement for &#8220;inducement grants&#8221; provided under Rule 5635(c)(4) of the Nasdaq Listing Rules.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Powers of Board.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To determine (A) who will be granted Awards, (B) when and how each Award will be granted, (C) what type of Award will be granted, (D) the provisions of each Award (which need not be identical), including when a Participant will be permitted to exercise or otherwise receive cash or Common Stock under the Award, (E) the number of shares of Common Stock subject to, or the cash value of, an Award, and (F) the Fair Market Value applicable to an Award. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Awards.&nbsp;&nbsp;The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a>.</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">Plan or in any Award </font><font style="font-weight:normal;color:#000000;">Agreement, in a manner and to the extent it will deem necessary or expedient to make the Plan or Award fully effective.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To settle all controversies regarding the Plan and Awards granted under it.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or at which cash or shares of Common Stock may be issued in settlement thereof).&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref197144730"></a><font style="Background-color:#auto;text-decoration:none;">(v)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To suspend or terminate the Plan at any time.&nbsp;&nbsp;Except as otherwise provided in the Plan (including Section 2(b)(viii)) or an Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#8217;s rights under an outstanding Award without his or her written consent.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(vi)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to certain nonqualified deferred compensation under Section 409A of the Code and/or to make the Plan or Awards granted under the Plan exempt from or compliant with the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law.  If required by applicable law or listing requirements, and except as provided in Section&#160;9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan.&nbsp;&nbsp;Except as otherwise provided in the Plan (including Section 2(b)(viii)) or an Award Agreement, no amendment of the Plan will materially impair a Participant&#8217;s rights under an outstanding Award without his or her written consent.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(vii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of Rule 16b-3.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(viii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more outstanding Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however,</font><font style="font-weight:normal;color:#000000;"> that except as otherwise provided in the Plan (including this Section 2(b)(viii)) or an Award Agreement, no amendment of an outstanding Award will materially impair a Participant&#8217;s rights under such Award without his or her written consent.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing or anything in the Plan to the contrary, unless prohibited by applicable law, the Board may amend the terms of any outstanding Award or the Plan, or may suspend or terminate the Plan, without the affected Participant&#8217;s consent, (A) to clarify the manner of exemption from, or to bring the Award or the Plan into compliance with, Section 409A of the Code or (B) to comply with other applicable laws or listing requirements.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ix)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M97"></a><font style="Background-color:#auto;text-decoration:none;">(x)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees who are foreign nationals or employed outside the </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">2.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">United States (</font><font style="font-weight:normal;color:#000000;">provided that</font><font style="font-weight:normal;color:#000000;"><a name="_DV_M97"></a> Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction)</font><font style="font-weight:normal;color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447106"></a><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Delegation to Committee.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M77"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">General.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Board may delegate some or all of the administration of the Plan to a Committee or Committees.&nbsp;&nbsp;If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable).&nbsp;&nbsp;Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable).&nbsp;&nbsp;The Committee may, at any time, abolish the subcommittee and/or revest in the Committee any powers delegated to the subcommittee.&nbsp;&nbsp;The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M78"></a><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Rule 16b-3 Compliance.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Committee may consist solely of two or more Non-Employee Directors in accordance with Rule 16b-3.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M80"></a><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Effect of Board&#8217;s Decision.</font><font style="font-weight:normal;color:#000000;">  All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Cancellation and Re-Grant of Awards.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Neither the Board nor any Committee will have the authority to (i) reduce the exercise or strike price of any outstanding Option or SAR or (ii) cancel any outstanding Option or SAR that has an exercise or strike price (per share) greater than the then-current Fair Market Value of the Common Stock in exchange for cash or other Awards under the Plan, unless the stockholders of the Company have approved such an action within 12 months prior to such an event.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(f)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Dividends and Dividend Equivalents.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of Common Stock subject to an Award, as determined by the Board and contained in the applicable Award Agreement; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">, that (i) no dividends or dividend equivalents may be paid with respect to any such shares before the date such shares have vested under the terms of such Award Agreement, (ii) any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of such Award Agreement (including, but not limited to, any vesting conditions), and (iii) any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref218923280"></a><font style="Background-color:#auto;text-decoration:none;">3.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Shares Subject to the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref126996582"></a><a name="_Ref38179407"></a><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Share Reserve.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">3.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="OLE_LINK7"></a><a name="OLE_LINK8"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards from and after the Effective Date will not exceed 1,500,000 shares (the &#8220;</font><font style="font-style:italic;color:#000000;">Share Reserve</font><font style="font-weight:normal;color:#000000;">&#8221;).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">For clarity, the Share Reserve in this Section 3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant to the Plan.&nbsp;&nbsp;Accordingly, this Section 3(a) does not limit the granting of Awards except as provided in Section 7(a).&nbsp;&nbsp;Shares may be issued in connection with a merger or acquisition as permitted by Nasdaq Listing Rule 5635(c) or, if applicable, NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref126997548"></a><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Reversion of Shares to the Share Reserve.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref309392648"></a><a name="_Ref320274575"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Shares Available for Subsequent Issuance.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">The following shares of Common Stock will become available again for issuance under the Plan: (A) any shares subject to an Award that are not issued because such Award or any portion thereof expires or otherwise terminates without all of the shares covered by such Award having been issued; (B) any shares subject to an Award that are not issued because such Award or any portion thereof is settled in cash; and (C) any shares issued pursuant to an Award that are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Shares Not Available for Subsequent Issuance.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">The following shares of Common Stock will not become available again for issuance under the Plan: (A) any shares that are reacquired or withheld (or not issued) by the Company to satisfy the exercise, strike or purchase price of an Award (including any shares subject to such Award that are not delivered because such Award is exercised through a reduction of shares subject to such Award (</font><font style="font-style:italic;font-weight:normal;color:#000000;">i.e</font><font style="font-weight:normal;color:#000000;">., &#8220;net exercised&#8221;)); (B) any shares that are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation </font><font style="color:#auto;font-weight:normal;"><strike Style="text-decoration:none;">in connection with </strike></font><font style="font-weight:normal;color:#000000;">an Award; (C) any shares repurchased by the Company on the open market with the proceeds of the exercise, strike or purchase price of an Award; and (D) in the event that a Stock Appreciation Right granted under the Plan is settled in shares of Common Stock, the gross number of shares of Common Stock subject to such Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Source of Shares.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">4.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Eligibility.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Eligibility for Awards.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Awards may only be granted to persons who are Employees described in Section 1(a), where the Award is an inducement material to the individual&#8217;s entering into employment with the Company or an Affiliate within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules.&nbsp;&nbsp;For clarity, Awards may not be granted to (1) Directors, for service in such capacity, or (2) any individual who was previously an Employee or Director, other than following a bona fide period of non-employment.&nbsp;&nbsp;Notwithstanding the foregoing, Awards may not be granted to Employees who are providing Continuous Service only </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">4</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405, unless (i) t</font><font style="font-weight:normal;color:#000000;">he stock underlying such </font><font style="font-weight:normal;color:#000000;">Awards is treated as &#8220;service recipient stock&#8221; under Section 409A of the Code </font><font style="font-weight:normal;color:#000000;">(for example, because the </font><font style="font-weight:normal;color:#000000;">Awards are granted pursuant to a corporate transaction such as a spin off transaction) or (ii) the Company, in consultation with its legal counsel, has determined that such Awards are otherwise exempt from or alternatively comply with Section 409A of the Code.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447396"></a><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Approval Requirements.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;All Awards must be granted either by a majority of the Company&#8217;s independent directors or by the Company&#8217;s compensation committee comprised of independent directors within the meaning of Rule 5605(a)(2) of the Nasdaq Listing Rules.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M89"></a><a name="_Ref92447500"></a><font style="Background-color:#auto;text-decoration:none;">5.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Provisions Relating to Options and Stock Appreciation Rights.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each Option or SAR Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate.&nbsp;&nbsp;All Options will be Nonstatutory Stock Options.  The terms and conditions of separate Option or SAR Agreements need not be identical; <font style="font-style:italic;">provided, however</font>, that each Award Agreement will conform to (through incorporation of the provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions:</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Term.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;No Option or SAR will be exercisable after the expiration of seven years from the date of its grant or such shorter period specified in the Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Exercise or Strike Price.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The exercise or strike price (per share) of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock on the date the Award is granted.&nbsp;&nbsp;Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price (per share) less than 100% of the Fair Market Value of the Common Stock on the date the Award is granted if such Award is granted pursuant to an assumption of, or substitution for, another option or stock appreciation right pursuant to a Transaction and in a manner consistent with the provisions of Section 409A of the Code.&nbsp;&nbsp;Each SAR will be denominated in shares of Common Stock equivalents.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447428"></a><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Payment of Exercise Price for Options.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The exercise price of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by one or more of the methods of payment set forth below that are specified in the Option Agreement.&nbsp;&nbsp;The Board has the authority to grant Options that do not permit all of the following methods of payment (or that otherwise restrict the ability to utilize certain methods) and to grant Options that require the consent of the Company to utilize a particular method of payment.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">By cash (including electronic funds transfers), check, bank draft or money order payable to the Company;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">By delivery to the Company (either by actual delivery or attestation) of shares of Common Stock;</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">5</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M187"></a><font style="text-decoration:none;Background-color:#auto;">(iv)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">B</font><font style="font-weight:normal;color:#000000;"><a name="_DV_M187"></a>y a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock </font><font style="font-weight:normal;color:#000000;">issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">,</font><font style="font-weight:normal;color:#000000;"> that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued.&nbsp;&nbsp;Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A) shares issuable upon exercise are used to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered to the Participa</font><font style="font-weight:normal;color:#000000;">nt as a result of such exercise</font><font style="font-weight:normal;color:#000000;">,</font><font style="font-weight:normal;color:#000000;"> and (C) shares are withheld to satisfy tax withholding obligations; or</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(v)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">In any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M124"></a><a name="_DV_M125"></a><a name="_DV_M126"></a><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Exercise and Payment of a SAR.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Award Agreement evidencing such SAR.&nbsp;&nbsp;The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A)&#160;the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date<a name="_DV_M124"></a><a name="_DV_M125"></a><a name="_DV_M126"></a>.&nbsp;&nbsp;The appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Award Agreement evidencing such SAR.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Transferability of Options and SARs.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board will determine.&nbsp;&nbsp;In the absence of such a determination by the Board to the contrary, the restrictions set forth in this Section 5(e) on the transferability of Options and SARs will apply.&nbsp;&nbsp;Notwithstanding the foregoing or anything in the Plan or an Award Agreement to the contrary, no Option or SAR may be transferred to any financial institution without prior stockholder approval.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447444"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Restrictions on Transfer.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;An Option or SAR will not be transferable, except by will or by the laws of descent and distribution (and pursuant to Sections 5(e)(ii) and 5(e)(iii) below), and will be exercisable during the lifetime of the Participant only by the Participant.&nbsp;&nbsp;Subject to the foregoing paragraph, the Board may, in its sole discretion, permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws.&nbsp;&nbsp;Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Domestic Relations Orders.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations Section 1.421-1(b)(2).</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">6</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Beneficiary Designation.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise.&nbsp;&nbsp;In the absence of such a designation, </font><font style="font-weight:normal;color:#000000;">upon the death of the Participant, </font><font style="font-weight:normal;color:#000000;">the executor or administrator of the Participant&#8217;s estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. </font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(f)</font><font style="font-weight:normal;margin-left:180pt;color:#000000;"></font><font style="color:#000000;">Vesting.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal.&nbsp;&nbsp;The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate.&nbsp;&nbsp;The vesting provisions of individual Options or SARs may vary.&nbsp;&nbsp;The provisions of this Section 5(f) are subject to any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(g)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Termination of Continuous Service.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date that is three months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement.&nbsp;&nbsp;If, after such termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time period, the Option or SAR (as applicable) will terminate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M102"></a><font style="Background-color:#auto;text-decoration:none;">(h)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Extension of Termination Date.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate,</font><font style="color:#000000;"> </font><font style="font-weight:normal;color:#000000;">if the exercise of an Option or SAR following the termination of a Participant&#8217;s Continuous Service (other than for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement.&nbsp;&nbsp;In addition, except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of a Participant&#8217;s Continuous Service (other than for Cause) would violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">7.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">expiration of a </font><font style="font-weight:normal;color:#000000;">total </font><font style="font-weight:normal;color:#000000;">period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the C</font><font style="font-weight:normal;color:#000000;">ompany&#8217;s insider trading policy</font><font style="font-weight:normal;color:#000000;"> or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M103"></a><a name="_DV_M232"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Disability of Participant.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date that is 12<a name="_DV_M232"></a> months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii)&#160;the expiration of the term of the Option or SAR as set forth in the Award Agreement.&nbsp;&nbsp;If, after such termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time period, the Option or SAR (as applicable) will terminate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M104"></a><a name="_DV_M105"></a><font style="Background-color:#auto;text-decoration:none;">(j)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Death of Participant.</font><font style="font-weight:normal;color:#000000;"><a name="_DV_M105"></a>&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) a Participant dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#8217;s Continuous Service (for a reason other than death), then the Participant&#8217;s Option or SAR may be exercised (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance, or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death, but only within such period of time ending on the earlier of (i) the date that is 18 months following the date of death (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement.&nbsp;&nbsp;If, after the Participant&#8217;s death, the Option or SAR (as applicable) is not exercised within the applicable time period, the Option or SAR (as applicable) will terminate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M106"></a><a name="_DV_M107"></a><font style="Background-color:#auto;text-decoration:none;">(k)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Termination for Cause.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Except as explicitly provided otherwise in the applicable Award Agreement or other individual written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Option or SAR will terminate immediately upon such termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(l)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Non-Exempt Employees.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six months following the date of grant of the Option or SAR (although the Award may vest prior to such date).  Consistent with the provisions of the Worker Economic Opportunity Act, (i) if such non-exempt employee dies or suffers a Disability, (ii) upon a Transaction in which such Option or SAR is not assumed, continued or substituted, (iii) upon a Change in Control, or (iv) upon the </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">8</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">Participant&#8217;s retirement (as such term may be defined in the Participant&#8217;s Award Agreement, in another </font><font style="font-weight:normal;color:#000000;">written </font><font style="font-weight:normal;color:#000000;">agreement between the Participant and the Company</font><font style="font-weight:normal;color:#000000;"> or an Affiliate</font><font style="font-weight:normal;color:#000000;">, or, if no such definition,</font><font style="font-weight:normal;color:#000000;"> in accordance with the Company&#8217;</font><font style="font-weight:normal;color:#000000;">s </font><font style="font-weight:normal;color:#000000;">or Affiliate&#8217;s </font><font style="font-weight:normal;color:#000000;">then current employment policies and guidelines), the vested portion of any Options and SARs may be</font><font style="font-weight:normal;color:#000000;"> exercised earlier than six</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">months following the date of grant.&nbsp;&nbsp;The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. </font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">To the extent permitted and/or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of a</font><font style="font-weight:normal;color:#000000;">ny shares under any other </font><font style="font-weight:normal;color:#000000;">Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Sect</font><font style="font-weight:normal;color:#000000;">ion 5(l) will apply to all</font><font style="font-weight:normal;color:#000000;"> Awards and are hereby incorporat</font><font style="font-weight:normal;color:#000000;">ed by reference into such </font><font style="font-weight:normal;color:#000000;">Award Agreements.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M127"></a><a name="_Ref92447517"></a><font style="Background-color:#auto;text-decoration:none;">6.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Provisions of Awards Other than Options and SARs.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M115"></a><a name="_Ref92447180"></a><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Restricted Stock Awards.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate.&nbsp;&nbsp;To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common Stock underlying a Restricted Stock Award may be (i) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted Stock Award lapse, or (ii)&#160;evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board.&nbsp;&nbsp;The terms and conditions of separate Restricted Stock Award Agreements need not be identical; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">, that each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Consideration.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;A Restricted Stock Award may be awarded in consideration for (A) cash (including electronic funds transfers), check, bank draft or money order payable to the Company or (B) any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Vesting.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">Shares of Common Stock awarded under a Restricted Stock Award Agreement may be subject to forfeiture to or repurchase by the Company in accordance with a vesting schedule to be determined by the Board.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Termination of Continuous Service.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;If a Participant&#8217;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have not vested as of the date of such termination under the terms of the Participant&#8217;s Restricted Stock Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Transferability.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Rights to acquire shares of Common Stock under a Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement.&nbsp;&nbsp;Notwithstanding the foregoing or anything in the Plan or a Restricted Stock Award Agreement to </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">9</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">the contrary, no Restricted Stock Award may be transferred to any financial institution without prior stockholder approval. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447212"></a><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Restricted Stock Unit Awards.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate.&nbsp;&nbsp;The terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">, that each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M116"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Consideration.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award.  The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M117"></a><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Vesting.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M118"></a><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Payment.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M119"></a><a name="_DV_M120"></a><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Additional Restrictions.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to the Restricted Stock Unit Award to a time after the vesting of the<a name="_DV_M120"></a> Restricted Stock Unit Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M121"></a><font style="Background-color:#auto;text-decoration:none;">(v)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Termination of Continuous Service.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates, any portion of the Participant&#8217;s Restricted Stock Unit Award that has not vested as of the date of such termination will be forfeited upon such termination.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M128"></a><a name="_Ref93290191"></a><a name="_Ref92447151"></a><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Performance Stock Awards.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="OLE_LINK1"></a><a name="OLE_LINK2"></a><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">General.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;A Performance Stock Award is an Award that is payable (including that may be granted, vest or be exercised) contingent upon the attainment during a Performance Period of specified Performance Goals.&nbsp;&nbsp;A Performance Stock Award may, but need not, require the Participant&#8217;s completion of a specified period of Continuous Service.&nbsp;&nbsp;The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Board, in its sole discretion.&nbsp;&nbsp;In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">10</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Board Discretion.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">With respect to any Performance Stock Award, </font><font style="font-weight:normal;color:#000000;">t</font><font style="font-weight:normal;color:#000000;">he Board</font><font style="font-weight:normal;color:#000000;"> retains the discretion to </font><font style="font-weight:normal;color:#000000;">(A) </font><font style="font-weight:normal;color:#000000;">reduce or eliminate the compensation or economic benefit due upon </font><font style="font-weight:normal;color:#000000;">the attainment of any</font><font style="font-weight:normal;color:#000000;"> Performance Goals on the basis of any con</font><font style="font-weight:normal;color:#000000;">siderations as the Board</font><font style="font-weight:normal;color:#000000;">, in its sole discretion, may determine</font><font style="font-weight:normal;color:#000000;"> and</font><font style="font-weight:normal;color:#000000;"> (B) </font><font style="font-weight:normal;color:#000000;">define the manner of calculating the Performance Criteria it selects to use for a Performance Period</font><font style="font-weight:normal;color:#000000;">.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref218923439"></a><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Other Stock Awards. </font><font style="font-weight:normal;color:#000000;"> Other forms of Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (</font><font style="font-style:italic;font-weight:normal;color:#000000;">e.g</font><font style="font-weight:normal;color:#000000;">., options or stock appreciation rights with an exercise or strike price (per share) less than 100% of the Fair Market Value of the Common Stock on the date of grant) may be granted either alone or in addition to Awards granted under Section 5 and this Section 6.&nbsp;&nbsp;Subject to the provisions of the Plan (including, but not limited to, Section 2(f)), the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">7.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Covenants of the Company.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref218923207"></a><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Availability of Shares.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy then-outstanding Awards.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Securities Law Compliance.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan the authority required to grant Awards and to issue and sell shares of Common Stock upon exercise of the Awards; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">, that this undertaking will not require the Company to register under the Securities Act the Plan, any Award or any Common Stock issued or issuable pursuant to any such Award.&nbsp;&nbsp;If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Awards unless and until such authority is obtained.  A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant to the Award if such grant or issuance would be in violation of any applicable securities law.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">No Obligation to Notify or Minimize Taxes.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising an Award.&nbsp;&nbsp;Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised.&nbsp;&nbsp;The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">8.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Miscellaneous.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Use of Proceeds from Sales of Common Stock.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">Proceeds from the sale of shares of Common Stock issued pursuant to Awards will constitute general funds of the Company.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">11</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Corporate Action Constituting Grant of Awards.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of w</font><font style="font-weight:normal;color:#000000;">hen the instrument, certificate</font><font style="font-weight:normal;color:#000000;"> or letter evidencing the Award is communicated to, or </font><font style="font-weight:normal;color:#000000;">actually received</font><font style="font-weight:normal;color:#000000;"> or accepted by, the Participant.&nbsp;&nbsp;In the event that the corporate records (</font><font style="font-style:italic;font-weight:normal;color:#000000;">e.g</font><font style="font-weight:normal;color:#000000;">., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (</font><font style="font-style:italic;font-weight:normal;color:#000000;">e.g</font><font style="font-weight:normal;color:#000000;">., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement </font><font style="font-weight:normal;color:#000000;">or related grant documents </font><font style="font-weight:normal;color:#000000;">as a result of a clerical error in the papering of the Award Agreement</font><font style="font-weight:normal;color:#000000;"> or related grant documents</font><font style="font-weight:normal;color:#000000;">, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement</font><font style="font-weight:normal;color:#000000;"> or related grant documents</font><font style="font-weight:normal;color:#000000;">.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Stockholder Rights.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to an Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to such Award has been entered into the books and records of the Company.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">No Employment or Other Service Rights.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, or (ii) the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Change in Time Commitment.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company or any Affiliate is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (i) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (ii) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award.  In the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(f)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Investment Assurances.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Award, (i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Award and (ii) to give written assurances satisfactory to the Company </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">12</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">stating that the Participant is acquiring Common Stock subject to the Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise distributing the Common Stock.&nbsp;&nbsp;The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition </font><font style="font-weight:normal;color:#000000;">of Common Stock under the </font><font style="font-weight:normal;color:#000000;">Award has been registered under a then currently effective registration sta</font><font style="font-weight:normal;color:#000000;">tement under the Securities Act</font><font style="font-weight:normal;color:#000000;"> or (B) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws.&nbsp;&nbsp;The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref218923266"></a><font style="Background-color:#auto;text-decoration:none;">(g)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Withholding Obligations.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state, local or foreign tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii)&#160;&#160;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; (iii) withholding cash from an Award settled in cash; (iv) withholding payment from any amounts otherwise payable to the Participant; or (v) by such other method as may be set forth in the Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(h)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Electronic Delivery.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Any reference herein to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Deferrals.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants.&nbsp;&nbsp;Deferrals by Participants will be made in accordance with Section 409A of the Code.&nbsp;&nbsp;Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company or an Affiliate.&nbsp;&nbsp;The Board is authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(j)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Section 409A.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code.  If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance with Section 409A of the Code, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">13</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment of any amount </font><font style="font-weight:normal;color:#000000;">under such Award </font><font style="font-weight:normal;color:#000000;">that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months and one day following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment may be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lum</font><font style="font-weight:normal;color:#000000;">p sum on the day after such six-</font><font style="font-weight:normal;color:#000000;">month period elapses, with the balance paid thereafter on the original schedule</font><font style="font-weight:normal;color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(k)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Clawback/Recovery.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.&nbsp;&nbsp;In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including, but not limited to, a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of Cause.&nbsp;&nbsp;No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company or an Affiliate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">9.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Adjustments upon Changes in Common Stock; Other Corporate Events.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447089"></a><a name="_Ref218923177"></a><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Capitalization Adjustments.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a); and (ii) the class(es) and number of securities and price per share of stock subject to outstanding Awards.&nbsp;&nbsp;The Board will make such adjustments and its determination will be final, binding and conclusive.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Dissolution or Liquidation.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, in the event of a dissolution or liquidation of the Company, all outstanding Awards (other than Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to a forfeiture condition or the Company&#8217;s right of repurchase may be reacquired or repurchased by the Company notwithstanding the fact that the holder of such Award is providing Continuous Service.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Transactions.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;In the event of a Transaction, the provisions of this Section 9(c) will apply to each outstanding Award unless otherwise provided in the instrument evidencing the Award, in any other written agreement between the Company or any Affiliate and the Participant, or in any director compensation policy of the Company.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">14</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Awards May Be Assumed.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;In the event of a </font><font style="font-weight:normal;color:#000000;">Transaction</font><font style="font-weight:normal;color:#000000;">, any </font><font style="font-weight:normal;color:#000000;">surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company)</font><font style="font-weight:normal;color:#000000;"> may assu</font><font style="font-weight:normal;color:#000000;">me or continue any or all </font><font style="font-weight:normal;color:#000000;">outstanding </font><font style="font-weight:normal;color:#000000;">Awards</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">or may substitute</font><font style="font-weight:normal;color:#000000;"> similar stock awards for </font><font style="font-weight:normal;color:#000000;">any or all </font><font style="font-weight:normal;color:#000000;">outstanding </font><font style="font-weight:normal;color:#000000;">Awards</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">(i</font><font style="font-weight:normal;color:#000000;">ncluding, but not limited to,</font><font style="font-weight:normal;color:#000000;"> award</font><font style="font-weight:normal;color:#000000;">s</font><font style="font-weight:normal;color:#000000;"> to acquire the same consideration paid to the stockholders of the Company pursuant to the </font><font style="font-weight:normal;color:#000000;">Transaction</font><font style="font-weight:normal;color:#000000;">)</font><font style="font-weight:normal;color:#000000;">, and any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to </font><font style="font-weight:normal;color:#000000;">any </font><font style="font-weight:normal;color:#000000;">outstanding </font><font style="font-weight:normal;color:#000000;">Awards</font><font style="font-weight:normal;color:#000000;"> may be assigned by the Company </font><font style="font-weight:normal;color:#000000;">to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company).&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">For clarity, in the event of a </font><font style="font-weight:normal;color:#000000;">Transaction</font><font style="font-weight:normal;color:#000000;">, </font><font style="font-weight:normal;color:#000000;">any</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) </font><font style="font-weight:normal;color:#000000;">may choose to assume or continue only a portion of a</font><font style="font-weight:normal;color:#000000;">n</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">outstanding </font><font style="font-weight:normal;color:#000000;">Award</font><font style="font-weight:normal;color:#000000;">,</font><font style="font-weight:normal;color:#000000;"> to </font><font style="font-weight:normal;color:#000000;">substitute a similar stock awa</font><font style="font-weight:normal;color:#000000;">rd for only a portion of an</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">outstanding </font><font style="font-weight:normal;color:#000000;">Award, or </font><font style="font-weight:normal;color:#000000;">to assume or continue</font><font style="font-weight:normal;color:#000000;">, or substitute similar stock awards for,</font><font style="font-weight:normal;color:#000000;"> the </font><font style="font-weight:normal;color:#000000;">outstanding </font><font style="font-weight:normal;color:#000000;">Awards</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">held by some, but not all</font><font style="font-weight:normal;color:#000000;">,</font><font style="font-weight:normal;color:#000000;"> Participants.&nbsp;&nbsp;The terms of any </font><font style="font-weight:normal;color:#000000;">such </font><font style="font-weight:normal;color:#000000;">assumption, continuation or substitution will be set by the Board.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Awards Held by Current Participants.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;In the event of a Transaction in which the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) does not assume or continue outstanding Awards, or substitute similar stock awards for outstanding Awards, then with respect to any such Awards that have not been assumed, continued or substituted and that are held by Participants whose Continuous Service has not terminated prior to the effective time of the Transaction (referred to as the &#8220;</font><font style="font-style:italic;color:#000000;">Current Participants</font><font style="font-weight:normal;color:#000000;">&#8221;), the vesting (and exercisability, if applicable) of such Awards will be accelerated in full (and with respect to Performance Stock Awards, vesting will be deemed to be satisfied at the target level of performance) to a date prior to the effective time of the Transaction (contingent upon the closing or completion of the Transaction) as the Board will determine (or, if the Board does not determine such a date, to the date that is five days prior to the effective time of the Transaction), and such Awards will terminate if not exercised (if applicable) prior to the effective time of the Transaction in accordance with the exercise procedures determined by the Board, and any reacquisition or repurchase rights held by the Company with respect to such Awards will lapse (contingent upon the closing or completion of the Transaction).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Awards Held by Participants other than Current Participants.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;In the event of a Transaction in which the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) does not assume or continue outstanding Awards, or substitute similar stock awards for outstanding Awards, then with respect to any such Awards that have not been assumed, continued or substituted and that are held by Participants other than Current Participants, such Awards will terminate if not exercised (if applicable) prior to the effective time of the Transaction in accordance with the exercise procedures determined by the Board; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided</font><font style="font-weight:normal;color:#000000;">, </font><font style="font-style:italic;font-weight:normal;color:#000000;">however</font><font style="font-weight:normal;color:#000000;">, that any reacquisition or repurchase rights held by the Company with respect to such Awards will not terminate and may continue to be exercised notwithstanding the Transaction.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Payment for Awards in Lieu of Exercise.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Notwithstanding the foregoing, in the event any outstanding Award held by a Participant will terminate if not exercised prior to the effective time of a Transaction, the Board may provide that the Participant may not exercise such Award but instead will receive a payment, in such form as may be determined by the Board, equal in value to the excess, if any, of (A)&#160;the value of the property the Participant would have </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">15</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">receive</font><font style="font-weight:normal;color:#000000;">d upon the exercise of such</font><font style="font-weight:normal;color:#000000;"> Award</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">immediately prior to the effective time of the </font><font style="font-weight:normal;color:#000000;">Transaction</font><font style="font-weight:normal;color:#000000;">, over (B)&#160;any exerc</font><font style="font-weight:normal;color:#000000;">ise price payable by the Participant</font><font style="font-weight:normal;color:#000000;"> in connection with s</font><font style="font-weight:normal;color:#000000;">uch exercise.&nbsp;&nbsp;For clarity, such</font><font style="font-weight:normal;color:#000000;"> payment may be </font><font style="font-weight:normal;color:#000000;">zero if the value of such</font><font style="font-weight:normal;color:#000000;"> property is equal to or less than the exercise price.&nbsp;&nbsp;Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Common Stock in connection with the </font><font style="font-weight:normal;color:#000000;">Transaction</font><font style="font-weight:normal;color:#000000;"> is delayed as a result of escrows, earn outs, holdbacks or any other contingencies</font><font style="font-weight:normal;color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Change in Control.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Unless provided otherwise in the Award Agreement for an Award, in any other written agreement or plan between the Company or any Affiliate and the Participant, or in any director compensation policy of the Company, an Award will not be subject to additional acceleration of vesting and exercisability upon or after a Change in Control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Parachute Payments.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">Except as otherwise provided in the applicable Award Agreement or other written agreement between a Participant and the Company or an Affiliate, if any payment or benefit the Participant would receive pursuant to a Change in Control from the Company or otherwise (&#8220;</font><font style="font-style:italic;color:#000000;">Payment</font><font style="font-weight:normal;color:#000000;">&#8221;) would (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;</font><font style="font-style:italic;color:#000000;">Excise Tax</font><font style="font-weight:normal;color:#000000;">&#8221;), then such Payment will be equal to the Reduced Amount.&nbsp;&nbsp;The &#8220;</font><font style="font-style:italic;color:#000000;">Reduced Amount</font><font style="font-weight:normal;color:#000000;">&#8221; will be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in the Participant&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.&nbsp;&nbsp;If a reduction in payments or benefits constituting &#8220;parachute payments&#8221; is necessary so that the Payment equals the Reduced Amount, reduction will occur in the following order: (A) reduction of cash payments; (B) cancellation of accelerated vesting of equity awards other than stock options; (C) cancellation of accelerated vesting of stock options; and (D) reduction of other benefits paid to the Participant.&nbsp;&nbsp;Within any such category of payments and benefits (that is, (A), (B), (C) or (D)), a reduction will occur first with respect to amounts that are not &#8220;deferred compensation&#8221; within the meaning of Section 409A of the Code and then with respect to amounts that are.&nbsp;&nbsp;In the event that acceleration of compensation from a Participant&#8217;s equity awards is to be reduced, such acceleration of vesting will be canceled, subject to the immediately preceding sentence, in the reverse order of the date of grant.&nbsp;&nbsp;The accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control will perform the foregoing calculations.&nbsp;&nbsp;If the accounting firm so engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, the Company will appoint a nationally recognized accounting firm to make the determinations required hereunder.&nbsp;&nbsp;The Company will bear all expenses with respect to the determinations by such accounting firm required to be made hereunder.&nbsp;&nbsp;The accounting firm engaged to make the determinations hereunder will provide its calculations, together with detailed supporting documentation, to the Participant and the Company within 15 calendar days after the date on which the Participant&#8217;s right to a Payment is triggered (if requested at that time by the Participant or the Company) or such other time as reasonably requested by the Participant or the Company.&nbsp;&nbsp;Any good faith determinations of the accounting firm made hereunder will be final, binding and conclusive upon the Participant and the Company.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">16</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447246"></a><font style="text-decoration:none;Background-color:#auto;">10.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Termination or Suspension of the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Termination or Suspension.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Board may suspend or terminate the Plan at any time.&nbsp;&nbsp;No Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">No Impairment of Rights.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Suspension or termination of the Plan will not materially impair rights and obligations under any Award granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan (including Section 2(b)(viii)) or an Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447127"></a><font style="Background-color:#auto;text-decoration:none;">11.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Effective Date of Plan.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Plan will become effective on the Effective Date.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">12.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Choice of Law.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The laws of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#8217;s conflict of laws rules.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">13.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Definitions.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">As used in the Plan, the following definitions will apply to the capitalized terms indicated below:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(a)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Affiliate</font><font style="font-weight:normal;color:#000000;">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405.&nbsp;&nbsp;The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(b)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Award</font><font style="font-weight:normal;color:#000000;">&#8221; means a Nonstatutory Stock Option, a Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award, a Performance Stock Award or any Other Stock Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(c)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Award Agreement</font><font style="font-weight:normal;color:#000000;">&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of an Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(d)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Board</font><font style="font-weight:normal;color:#000000;">&#8221; means the Board of Directors of the Company.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(e)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Capitalization Adjustment</font><font style="font-weight:normal;color:#000000;">&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards No. 123 (revised).&nbsp;&nbsp;Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">17</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(f)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Cause</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">will have the meaning ascribed to such term in any written agreement </font><font style="font-weight:normal;color:#000000;">between a Participant and the Company or an Affiliate</font><font style="font-weight:normal;color:#000000;"> defining such term and, in the absence of such agreement, such term means, </font><font style="font-weight:normal;color:#000000;">with respect to a Participant, the occurrence o</font><font style="font-weight:normal;color:#000000;">f one or more of the following</font><font style="font-weight:normal;color:#000000;">:</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">(i) </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant&#8217;s theft, dishonesty, willful misconduct, breach of fiduciary duty for personal profit, or falsification of any Company or Affiliat</font><font style="font-weight:normal;color:#000000;">e documents or records; (ii) </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant&#8217;s material failure to abide by the code of conduct or other policies (including, without limitation, policies relating to confidentiality an</font><font style="font-weight:normal;color:#000000;">d reasonable workplace conduct) </font><font style="font-weight:normal;color:#000000;">of the</font><font style="font-weight:normal;color:#000000;"> Company or an Affiliate; (iii) </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant&#8217;s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible ass</font><font style="font-weight:normal;color:#000000;">et or corporate opportunity of the Company or an Affiliate </font><font style="font-weight:normal;color:#000000;">(in</font><font style="font-weight:normal;color:#000000;">cluding, without limitation, </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant&#8217;s improper use or disclosure of confidential or proprietary information of the Compan</font><font style="font-weight:normal;color:#000000;">y or an Affiliate); (iv) any intentional act by </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant which has a material detrimental effect on the reputation or business of t</font><font style="font-weight:normal;color:#000000;">he Company or an Affiliate; (v) </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant&#8217;s repeated failure or inability to perform any reasonable assigned duties after written notice from the Company or an Affiliate, and a reasonable opportunity to c</font><font style="font-weight:normal;color:#000000;">ure, such failure or inability; (vi) any material breach by </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant of any employment </font><font style="font-weight:normal;color:#000000;">or service agreement between </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant and the Company or an Affiliate, which breach is not cured pursuant to the te</font><font style="font-weight:normal;color:#000000;">rms of such agreement; or (vii) </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant&#8217;s conviction (including any plea of guilty or nolo contendere)&#160;of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or whic</font><font style="font-weight:normal;color:#000000;">h impairs </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant&#8217;s abilit</font><font style="font-weight:normal;color:#000000;">y to perform his or her duties.&nbsp;&nbsp;The determination that a termination of a Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Company, in its sole discretion.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Award</font><font style="font-weight:normal;color:#000000;">s held by </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant will</font><font style="font-weight:normal;color:#000000;"> have no effect upon any determination of the rights or obligations of the Company or </font><font style="font-weight:normal;color:#000000;">the</font><font style="font-weight:normal;color:#000000;"> Participant for any other purpose.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(g)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Change in Control</font><font style="font-weight:normal;color:#000000;">&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50%&#160;of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.&nbsp;&nbsp;Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A)&#160;on account of the acquisition of securities of the Company directly from the Company, (B)&#160;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&#160;solely because the level of Ownership held by any Exchange Act Person (the &#8220;</font><font style="font-style:italic;color:#000000;">Subject Person</font><font style="font-weight:normal;color:#000000;">&#8221;)&#160;exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence)&#160;as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur;</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">18</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">there is consummated a merger, consolidation or similar transaction involving (directly or indirectly)&#160;the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A)&#160;outstanding voting securities representing more than </font><font style="font-weight:normal;color:#000000;">50%&#160;</font><font style="font-weight:normal;color:#000000;">of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&#160;more than </font><font style="font-weight:normal;color:#000000;">50%&#160;</font><font style="font-weight:normal;color:#000000;">of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction</font><font style="font-weight:normal;color:#000000;">;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50%&#160;of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">over a period of 12 months or less, individuals who, on the Effective Date, are members of the Board (the &#8220;</font><font style="font-style:italic;color:#000000;">Incumbent Board</font><font style="font-weight:normal;color:#000000;">&#8221;)&#160;cease for any reason to constitute at least a majority of the members of the Board; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">, that if the appointment or election (or nomination for election)&#160;of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board.</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Notwithstanding the foregoing or any other provision of this Plan, (A) the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B) the definition of Change in Control (or any analogous term) in an individual written agreement between a Participant and the Company or an Affiliate will supersede the foregoing definition with respect to Awards subject to such agreement; <font style="font-style:italic;">provided, however</font>, that (1) if no definition of Change in Control (or any analogous term) is set forth in such an individual written agreement, the foregoing definition will apply; and (2) no Change in Control (or any analogous term) will be deemed to occur with respect to Awards subject to such an individual written agreement without a requirement that the Change in Control (or any analogous term) actually occur.&nbsp;&nbsp;</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If required for compliance with Section 409A of the Code, in no event will an event be deemed a Change in Control if such event is not also a &#8220;change in the ownership of&#8221; the Company, a &#8220;change in the effective control of&#8221; the Company or a &#8220;change in the ownership of a substantial portion of the assets of&#8221; the Company, each as determined under Treasury Regulations Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).&nbsp;&nbsp;The Board may, in its sole discretion and without a Participant&#8217;s consent, amend the definition of &#8220;Change in Control&#8221; to conform to the definition of a &#8220;change in control event&#8221; under Section 409A of the Code and the regulations thereunder.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(h)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Code</font><font style="font-weight:normal;color:#000000;">&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">19</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Committee</font><font style="font-weight:normal;color:#000000;">&#8221; means a committee of</font><font style="font-weight:normal;color:#000000;"> two</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">or more Directors to whom authority has been delegated by the Board in accordance with Section </font><font style="font-weight:normal;color:#000000;">2(c)</font><font style="font-weight:normal;color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(j)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Common Stock</font><font style="font-weight:normal;color:#000000;">&#8221; means the common stock of the Company.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(k)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Company</font><font style="font-weight:normal;color:#000000;">&#8221; means Dynavax Technologies Corporation, a Delaware corporation. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(l)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Continuous Service</font><font style="font-weight:normal;color:#000000;">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee or Director, is not interrupted or terminated.&nbsp;&nbsp;A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee or Director or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service; </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however,</font><font style="font-weight:normal;color:#000000;"> that</font><font style="font-style:italic;font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate.&nbsp;&nbsp;For example, a change in status from an Employee of the Company to a Director will not constitute an interruption of Continuous Service.&nbsp;&nbsp;To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate or their successors.&nbsp;&nbsp;Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s or Affiliate&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(m)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Corporate Transaction</font><font style="font-weight:normal;color:#000000;">&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">the consummation of a sale</font><font style="color:#000000;"> </font><font style="font-weight:normal;color:#000000;">or other disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">the consummation of a sale or other disposition of at least 90%&#160;of the outstanding securities of the Company;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">the consummation of a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(iv)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">the consummation of a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:0%;white-space:nowrap">
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">If required for compliance with Section 409A of the Code, in no event will an event be deemed a Corporate Transaction if such event is not also a &#8220;change in the ownership of&#8221; the </p></td></tr></table></div>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">20</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:0%;white-space:nowrap"></td>
<td valign="top">
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company, a &#8220;change in the ef</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">fective control of&#8221; the Company</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> or a &#8220;change in the ownership of a substantial portion of the assets of&#8221; the Company, each as determined under Treasury Regulations Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder)</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.&nbsp;&nbsp;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board may, in its sole discretion and without a Participant&#8217;s consent, amend the definition of &#8220;</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate Transaction</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8221; to conform to the definition of a &#8220;change in control event&#8221; under Section 409A of the Code </font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and the regulations thereunder.</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(n)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Director</font><font style="font-weight:normal;color:#000000;">&#8221; means a member of the Board.&nbsp;&nbsp;Directors are not eligible to receive Awards with respect to their service in such capacity.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(o)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Disability</font><font style="font-weight:normal;color:#000000;">&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(p)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Effective Date</font><font style="font-weight:normal;color:#000000;">&#8221; means the effective date of this Plan, which is the date the Plan was approved by the Compensation Committee of the Board.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(q)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Employee</font><font style="font-weight:normal;color:#000000;">&#8221; means any person employed by the Company or an Affiliate.&nbsp;&nbsp;However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(r)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Entity</font><font style="font-weight:normal;color:#000000;">&#8221; means a corporation, partnership, limited liability company or other entity.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(s)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Exchange Act</font><font style="font-weight:normal;color:#000000;">&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(t)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Exchange Act Person</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company, or (v) any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than fifty percent 50% of the combined voting power of the Company&#8217;s then outstanding securities.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(u)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Fair Market Value</font><font style="font-weight:normal;color:#000000;">&#8221; means, as of any date, the value of the Common Stock determined as follows:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(i)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Unless otherwise provided by the Board, if the Common Stock is listed on any established stock exchange or traded on any established market, then the Fair Market Value of a share of Common Stock will be the closing sales price for such stock as quoted on such </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">21</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value of a share of Common Stock will be the closing sales price for such stock on the last preceding date for which such quotation exists.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_Ref92447285"></a><font style="Background-color:#auto;text-decoration:none;">(iii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">In the absence of such markets for the Common Stock, the Fair Market Value of a share of Common Stock will be determined by the Board in good faith and in a manner that complies with Section 409A of the Code. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(v)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Non-Employee Director</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="color:#000000;"> </font><font style="font-weight:normal;color:#000000;">means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;</font><font style="font-style:italic;color:#000000;">Regulation S-K</font><font style="font-weight:normal;color:#000000;">&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item&#160;404(b) of Regulation S-K, or (ii) is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(w)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Nonstatutory Stock Option</font><font style="font-weight:normal;color:#000000;">&#8221; means an option granted pursuant to Section 5 that does not qualify as an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(x)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Officer</font><font style="font-weight:normal;color:#000000;">&#8221; means a person who is an officer of the Company within the meaning of Section&#160;16 of the Exchange Act. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(y)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Option</font><font style="font-weight:normal;color:#000000;">&#8221; means a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(z)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Option Agreement</font><font style="font-weight:normal;color:#000000;">&#8221; means a written agreement between the Company and a holder of an Option evidencing the terms and conditions of an Option grant.&nbsp;&nbsp;Each Option Agreement will be subject to the terms and conditions of the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(aa)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Other Stock Award</font><font style="font-weight:normal;color:#000000;">&#8221; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section 6(d).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M50"></a><font style="Background-color:#auto;text-decoration:none;">(bb)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Other Stock Award Agreement</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant.&nbsp;&nbsp;Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(cc)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Own,</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Owned,</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Owner,</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Ownership</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="color:#000000;"> </font><font style="font-weight:normal;color:#000000;"> A person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">22</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(dd)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Participant</font><font style="font-weight:normal;color:#000000;">&#8221; means </font><font style="font-weight:normal;color:#000000;">with respect to any Award, a person to whom such</font><font style="font-weight:normal;color:#000000;"> Award is granted pursuant to the Plan or, if applicable, such other perso</font><font style="font-weight:normal;color:#000000;">n who holds an outstanding</font><font style="font-weight:normal;color:#000000;"> Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ee)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Performance Criteria</font><font style="font-weight:normal;color:#000000;">&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period.&nbsp;&nbsp;The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following, as determined by the Board: (i) earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii) earnings before interest, taxes, depreciation and amortization (EBITDA); (iv) total stockholder return; (v) return on equity or average stockholder&#8217;s equity; (vi) return on assets, investment, or capital employed; (vii) stock price or stock price performance; (viii) margin (including gross margin); (ix) net income (before or after taxes); (x) operating income; (xi) operating income after taxes; (xii) pre-tax profit; (xiii) operating cash flow; (xiv) sales or revenue targets; (xv) increases in revenue or product revenue; (xvi) expenses and cost reduction goals; (xvii) improvement in or attainment of working capital levels; (xviii) economic value added (or an equivalent metric); (xix) market share; (xx) cash flow; (xxi) cash flow per share; (xxii) share price performance; (xxiii) debt reduction; (xxiv) implementation or completion of projects or processes; (xxv) customer satisfaction; (xxvi) stockholders&#8217; equity; (xxvii) capital expenditures; (xxviii) debt levels; (xxix) operating profit or net operating profit; (xxx) workforce diversity; (xxxi) growth of net income or operating income; (xxxii) billings; (xxxiii) submission to, or approval by, a regulatory body (including but not limited to the U.S. Food and Drug Administration) of an applicable filing for a product candidate or other product development milestones; (xxxiv) acquisitions, divestitures, joint ventures, strategic alliances, licenses or collaborations; (xxxv) spin-offs, split-ups, reorganizations, recapitalizations, restructurings, financings (debt or equity) or refinancings; (xxxvi) manufacturing or process development, clinical trial, regulatory, intellectual property, compliance or research objectives; and (xxxvii)&#160;any other measures of performance selected by the Board.&nbsp;&nbsp;Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the applicable Award Agreement.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_C330"></a><a name="_DV_C331"></a><a name="_DV_C332"></a><a name="_DV_C333"></a><font style="Background-color:#auto;text-decoration:none;">(ff)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Performance Goals</font><font style="font-weight:normal;color:#000000;">&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria.&nbsp;&nbsp;Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices.&nbsp;&nbsp;The Board is authorized to make appropriate adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: <a name="_DV_C330"></a>(i)&#160;to exclude restructuring and/or other nonrecurring charges; (ii) to exclude exchange rate effects, as applicable, for non-U.S. dollar denominated Performance Goals; (iii) to exclude the effects of changes to generally accepted accounting principles; (iv) to exclude the effects of any statutory adjustments to corporate tax rates; (v)&#160;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (vi)&#160;to exclude the dilutive effects of acquisitions or joint ventures;<a name="_DV_C331"></a> (vii)&#160;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture;<a name="_DV_C332"></a> (viii)&#160;to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">23.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;"><a name="_DV_C333"></a>dividends; </font><font style="font-weight:normal;color:#000000;">(ix) to exclude the effects of stock based compensation and/or the award of an annual cash incentive under the Company&#8217;s </font><font style="font-weight:normal;color:#000000;">Annual Incentive Program; </font><font style="font-weight:normal;color:#000000;">(x) to exclude the effect of any other unusual, non-recurring gain or loss or other extraordinary item</font><font style="font-weight:normal;color:#000000;">; and (xi) to make other appropriate adjustments selected by </font><font style="font-weight:normal;color:#000000;">the Board</font><font style="font-weight:normal;color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(gg)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Performance Period</font><font style="font-weight:normal;color:#000000;">&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the payment of a Performance Stock Award.&nbsp;&nbsp;Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(hh)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Performance Stock Award</font><font style="font-weight:normal;color:#000000;">&#8221; means an Award granted under the terms and conditions of Section 6(c).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ii)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Plan</font><font style="font-weight:normal;color:#000000;">&#8221; means this Dynavax Technologies Corporation 2021 Inducement Award Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(jj)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Restricted Stock Award</font><font style="font-weight:normal;color:#000000;">&#8221; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(a).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(kk)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Restricted Stock Award Agreement</font><font style="font-weight:normal;color:#000000;">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant.&nbsp;&nbsp;Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(ll)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Restricted Stock Unit Award</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(b).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="_DV_M55"></a><font style="Background-color:#auto;text-decoration:none;">(mm)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Restricted Stock Unit Award Agreement</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant.&nbsp;&nbsp;Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(nn)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Rule 16b-3</font><font style="font-weight:normal;color:#000000;">&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(oo)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Rule 405</font><font style="font-weight:normal;color:#000000;">&#8221; means Rule 405 promulgated under the Securities Act.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(pp)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Securities Act</font><font style="font-weight:normal;color:#000000;">&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(qq)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Stock Appreciation Right</font><font style="font-weight:normal;color:#000000;">&#8221; or &#8220;</font><font style="font-style:italic;color:#000000;">SAR</font><font style="font-weight:normal;color:#000000;">&#8221;</font><font style="font-style:italic;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section 5.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(rr)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Stock Appreciation Right Agreement</font><font style="font-weight:normal;color:#000000;">&#8221; or &#8220;</font><font style="font-style:italic;color:#000000;">SAR Agreement</font><font style="font-weight:normal;color:#000000;">&#8221; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant.&nbsp;&nbsp;Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">24</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">(ss)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Subsidiary</font><font style="font-weight:normal;color:#000000;">&#8221; means, with respect to the Company, (i) any corporation of which more than </font><font style="font-weight:normal;color:#000000;">50%</font><font style="font-weight:normal;color:#000000;"> of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership</font><font style="font-weight:normal;color:#000000;">, limited liability company or other entity</font><font style="font-weight:normal;color:#000000;"> in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) </font><font style="font-weight:normal;color:#000000;">of more than 50%</font><font style="font-weight:normal;color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">(tt)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">&#8220;</font><font style="font-style:italic;color:#000000;">Transaction</font><font style="font-weight:normal;color:#000000;">&#8221; means a Corporate Transaction or a Change in Control.</font></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;">&nbsp;</p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">25</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">2021 <font style="font-family:Times New Roman;">Inducement Award</font> Plan</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;text-transform:none;font-variant: small-caps;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;">Option Grant Notice<br /></p>
<p style="margin-bottom:6pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221;) hereby grants to Participant an Option under the Dynavax Technologies Corporation 2021 Inducement Award Plan (the &#8220;<font style="font-weight:bold;font-style:italic;">Plan</font>&#8221;) to purchase the number of shares of Common Stock (the &#8220;<font style="font-weight:bold;font-style:italic;">Shares</font>&#8221;) set forth below at the exercise price set forth below.&nbsp;&nbsp;This Option is subject to all of the terms and conditions set forth in this Option Grant Notice (the &#8220;<font style="font-weight:bold;font-style:italic;">Grant Notice</font>&#8221;) and in the Option Agreement (the &#8220;<font style="font-weight:bold;font-style:italic;">Agreement</font>&#8221;) and the Plan, both of which are attached hereto and incorporated herein in their entirety.&nbsp;&nbsp;Capitalized terms not explicitly defined in this Grant Notice but defined in the Plan or the Agreement will have the same definitions as in the Plan or the Agreement. </p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:379.8pt;;">
<tr>
<td style="width:230.8pt;"></td>
<td style="width:149pt;"></td>
</tr>
<tr style="height:16.55pt;">
<td valign="bottom" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Participant:</p></td>
<td valign="bottom" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:15.3pt;">
<td valign="bottom" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date of Grant:</p></td>
<td valign="bottom" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:16.55pt;">
<td valign="bottom" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting Commencement Date:</p></td>
<td valign="bottom" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:16.55pt;">
<td valign="bottom" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of Shares Subject to Option:</p></td>
<td valign="bottom" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:16.55pt;">
<td valign="bottom" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price (Per Share):</p></td>
<td valign="bottom" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:16.55pt;">
<td valign="bottom" >
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Exercise Price:</p></td>
<td valign="bottom" >
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
<tr style="height:15.3pt;">
<td valign="bottom"  style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expiration Date:</p></td>
<td valign="bottom"  style=" border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Type of Grant:<font style="margin-left:90pt;"></font><font style="font-weight:normal;">Nonstatutory Stock Option</font></p>
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Schedule:<font style="font-weight:normal;margin-left:90pt;">Same as Vesting Schedule </font><font style="font-weight:normal;margin-left:252pt;"></font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:19.23%;white-space:nowrap">
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Vesting Schedule:</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-weight:normal;">Subject to Section 1 of the Agreement, this Option will vest as follows: [___________].</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:19.23%;white-space:nowrap">
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Payment:</font><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;"><font style="font-weight:normal;">By one or a combination of the following items (as described in the Agreement):</font></p></td></tr></table></div>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:19.23%;text-indent:0%;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><font style="font-size:12pt;font-family:'Times New Roman'">&#9746;</font><font style="font-family:Times New Roman;"> </font><font style="font-family:Times New Roman;margin-left:36pt;">By cash, check, bank draft or money order payable to the Company</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:19.23%;text-indent:0%;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><font style="font-size:12pt;font-family:'Times New Roman'">&#9746;</font><font style="font-family:Times New Roman;margin-left:36pt;">Pursuant to a Regulation T Program if the Common Stock is publicly traded</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:19.23%;text-indent:0%;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><font style="font-size:12pt;font-family:'Times New Roman'">&#9746;</font><font style="font-family:Times New Roman;margin-left:36pt;">By delivery of already-owned Shares if the Common Stock is publicly traded</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:19.23%;white-space:nowrap">
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"><font style="font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#9746;</font></p></td>
<td valign="top">
<p style="margin-bottom:10pt;text-align:justify;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">If and only to the extent this Option is a Nonstatutory Stock Option, and subject to the Company&#8217;s consent at the time of exercise, by a &#8220;net exercise&#8221; arrangement<sup style="font-size:85%;line-height:120%;vertical-align:top"> </sup></p></td></tr></table></div>
<p style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional Terms/Acknowledgements:<font style="font-weight:normal;">&nbsp;&nbsp;Participant acknowledges receipt of, and understands and agrees to, this Grant Notice, the Agreement and the Plan.&nbsp;&nbsp;Participant further acknowledges that as of the Date of Grant, this Grant Notice, the Agreement and the Plan set forth the entire understanding between Participant and the Company regarding this Option and supersede all prior oral and written agreements, promises and/or representations regarding this Option, with the exception of any written employment, offer letter or severance agreement, or any written severance plan or policy, in each case that specifies the terms that should govern this Option.&nbsp;&nbsp;By accepting </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a>.</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:6pt;margin-top:6pt;text-align:justify;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:normal;">this Option, Participant consents to receive this Grant Notice, the Agreement, the Plan, the prospectus for the Plan and any other Plan-related documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.&nbsp;&nbsp;Participant&#8217;s acceptance of this Option, and Participant&#8217;s acknowledgement and agreement with the terms set forth in this paragraph, will be evidenced by Participant&#8217;s signature below or by electronic acceptance or authentication in a form authorized by the Company.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:18.31%;text-indent:-18.31%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:478.8pt;;">
<tr>
<td style="width:239.4pt;"></td>
<td style="width:239.4pt;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="text-decoration:underline;"></font></p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature</p>
<p style="margin-bottom:6pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:<font style="text-decoration:underline;"></font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:<font style="text-decoration:underline;"></font></p></td>
<td valign="top" >
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Participant</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:<font style="text-decoration:underline;"></font></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:18.31%;text-indent:-18.31%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:18.27%;text-indent:-18.27%;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Attachments<font style="font-variant: normal;">:</font><font style="font-weight:normal;font-variant: normal;">&nbsp;&nbsp;Option Agreement and 2021 Inducement Award Plan</font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="margin-bottom:12pt;text-align:center;margin-top:0pt;text-indent:0%;font-size:14pt;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">2</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:12pt;text-align:center;margin-top:0pt;text-indent:0%;text-transform:none;font-variant: small-caps;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;">Attachment I</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">2021 <font style="font-family:Times New Roman;">Inducement Award</font> Plan</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-size:14.5pt;text-transform:none;font-variant: small-caps;font-weight:bold;font-family:Times New Roman;font-style:normal;"><br /><font style="font-size:14pt;">Option Agreement<br /></font><font style="font-size:12pt;">(Nonstatutory Stock Option)</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the accompanying Option Grant Notice (the &#8220;<font style="font-weight:bold;font-style:italic;">Grant Notice</font>&#8221;) and this Option Agreement (the &#8220;<font style="font-weight:bold;font-style:italic;">Agreement</font>&#8221;), Dynavax Technologies Corporation (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221;) has granted you an Option under the Dynavax Technologies Corporation 2021 Inducement Award Plan (the &#8220;<font style="font-weight:bold;font-style:italic;">Plan</font>&#8221;) to purchase the number of shares of Common Stock set forth in the Grant Notice at the exercise price set forth in the Grant Notice.&nbsp;&nbsp;This Option is granted to you effective as of the date of grant set forth in the Grant Notice (the &#8220;<font style="font-weight:bold;font-style:italic;">Date of Grant</font>&#8221;).&nbsp;&nbsp;Capitalized terms not explicitly defined in this Agreement but defined in the Plan or the Grant Notice will have the same definitions as in the Plan or the Grant Notice.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">1.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Vesting.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Subject to the limitations contained herein, this Option will vest, if at all, in accordance with the vesting schedule set forth in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">2.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Number of Shares and Exercise Price.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The number of shares of Common Stock subject to this Option and the exercise price per share of this Option, each as set forth in the Grant Notice, will be adjusted for Capitalization Adjustments, if any, as provided in the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">3.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Exercise Restriction for Non-Exempt Employees.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;In the event that you are an Employee eligible for overtime compensation under the Fair Labor Standards Act of 1938, as amended (</font><font style="font-style:italic;font-weight:normal;color:#000000;">i.e.</font><font style="font-weight:normal;color:#000000;">, a &#8220;</font><font style="font-style:italic;color:#000000;">Non-Exempt Employee</font><font style="font-weight:normal;color:#000000;">&#8221;), then except as otherwise provided in the Plan, you may not exercise this Option until you have completed at least six (6) months of Continuous Service following the Date of Grant, even if you have already been an Employee for more than six months.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">4.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Method of Payment.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;You must pay the full amount of the exercise price for the shares of Common Stock you wish to purchase.&nbsp;&nbsp;You may pay the exercise price in cash or by check, bank draft or money order payable to the Company or in any other manner </font><font style="font-style:italic;color:#000000;">permitted by the Grant Notice,</font><font style="font-weight:normal;color:#000000;"> which may include one or more of the following:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Provided that at the time of exercise the Common Stock is publicly traded, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of Common Stock, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Provided that at the time of exercise the Common Stock is publicly traded, by delivery to the Company (either by actual delivery or attestation) of already-owned shares of Common Stock that are owned free and clear of any liens, claims, encumbrances or security </font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a>.</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">interests, with a Fair Market Value on the date of exercise </font><font style="text-decoration:none;color:#auto;font-weight:normal;">that does not exceed the aggregate exercise price.&nbsp;&nbsp;You must pay any remaining balance of the aggregate exercise price not satisfied by such delivery in cash or other permitted form of payment</font><font style="font-weight:normal;color:#000000;">.&nbsp;&nbsp;&#8220;Delivery&#8221; for these purposes, in the sole discretion of the Company at the time you exercise this Option, will include delivery to the Company of your attestation of ownership of such shares of Common Stock in a form approved by the Company.&nbsp;&nbsp;Notwithstanding the foregoing, you may not exercise this Option by delivery to the Company of Common Stock if doing so would violate the provisions of any law, regulation or agreement restricting the redemption of the Company&#8217;s stock.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-style:italic;color:#000000;">Subject to the consent of the Company at the time of exercise</font><font style="font-weight:normal;color:#000000;">, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock otherwise issuable to you upon exercise of this Option by the largest number of whole shares of Common Stock with a Fair Market Value on the date of exercise that does not exceed the aggregate exercise price.&nbsp;&nbsp;You must pay any remaining balance of the aggregate exercise price not satisfied by such &#8220;net exercise&#8221; in cash or other permitted form of payment.&nbsp;&nbsp;Shares of Common Stock will no longer be outstanding under this Option and will not be exercisable thereafter if those shares (i) are used to pay the exercise price pursuant to a &#8220;net exercise,&#8221; (ii) are delivered to you as a result of such exercise, or (iii) are withheld to satisfy tax withholding obligations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">5.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Whole Shares.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;You may exercise this Option only for whole shares of Common Stock.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">6.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Securities Law Compliance.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, you may not exercise this Option unless either (i) the shares of Common Stock issuable upon such exercise are registered under the Securities Act or (ii) the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act.&nbsp;&nbsp;This Option also must comply with all other applicable laws and regulations governing this Option, and you may not exercise this Option if the Company determines that such exercise would not be in material compliance with such laws and regulations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">7.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Term.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;You may not exercise this Option before the Date of Grant or after the expiration of its term.&nbsp;&nbsp;The term of this Option expires, subject to the provisions of Section 5(h) of the Plan, upon the earliest of the following:</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">immediately upon the termination of your Continuous Service if such termination is for Cause;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">three (3) months after the termination of your Continuous Service if such termination is for any reason other than Cause, your Disability or your death (except as otherwise provided in Section 7(d) below); </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">, that if (i) you are a Non-Exempt Employee, (ii) your Continuous Service terminates within six (6) months after the Date of Grant, and (iii) you have vested in a portion of this Option as of the time of your termination of Continuous Service, then this Option will not expire until the earlier of (x) the later of (A) the date that is seven (7) months after the Date of Grant or (B) the date that is three (3) months after the termination of your Continuous Service, or (y) the Expiration Date set forth in the Grant Notice; </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">2</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">twelve (12) months after the termination of your Continuous Service if such termination is due to your Disability (except as otherwise provided in Section 7(d) below);</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">d.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">eighteen (18) months after your death if either your Continuous Service terminates due to your death or you die within three (3) months after your Continuous Service terminates for any reason other than Cause;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">e.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">the Expiration Date set forth in the Grant Notice; or</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">f.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">the day before the seventh (7th) anniversary of the Date of Grant.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">8.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Exercise.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">You may exercise the vested portion of this Option during its term by (i) (A) delivering a Notice of Exercise (in a form designated by the Company), or (B) taking such other action as the Company may require, and (ii) paying the exercise price and any applicable withholding taxes to the Company&#8217;s stock plan administrator, or to such other person as the Company may designate, together with such additional documents as the Company may then require.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">By exercising this Option, you agree that, as a condition to any exercise of this Option, the Company may require you to enter into an arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising by reason of (i) the exercise of this Option, (ii) the lapse of any substantial risk of forfeiture to which the shares of Common Stock are subject at the time of exercise, or (iii) the disposition of shares of Common Stock acquired upon such exercise.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">9.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Transferability.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Except as otherwise provided in this Section 9, this Option is not transferable, except by will or by the laws of descent and distribution, and is exercisable during your life only by you.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Certain Trusts.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Upon receiving written permission from the Board or its duly authorized designee, you may transfer this Option to a trust if you are considered to be the sole beneficial owner (determined under Section 671 of the Code and applicable state law) while this Option is held in the trust, provided that you and the trustee enter into transfer and other agreements required by the Company.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Domestic Relations Orders.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Upon receiving written permission from the Board or its duly authorized designee, and provided that you and the designated transferee enter into transfer and other agreements required by the Company, you may transfer this Option pursuant to a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by applicable law that contains the information required by the Company to effectuate the transfer.&nbsp;&nbsp;You are encouraged to discuss the proposed terms of any such transfer with the Company prior to finalizing such domestic relations order, marital settlement agreement or other divorce or separation instrument to help ensure the required information is contained within the domestic relations order, marital settlement agreement or other divorce or separation instrument.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">3</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="color:#000000;">Beneficiary Designation.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Upon receiving written permission from the Board or its duly authorized designee, you may, by delivering written notice to the Company, in a form approved by the Company and any broker designated by the Company to handle option exercises, designate a third party who, in the event of your death, will thereafter be entitled to exercise this Option and receive the Common Stock or other consideration resulting from such exercise.&nbsp;&nbsp;In the absence of such a designation, in the event of your death, the executor or administrator of your estate will be entitled to exercise this Option and receive, on behalf of your estate, the Common Stock or other consideration resulting from such exercise.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">10.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Option Not a Service Contract.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;This Option is not an employment or service contract, and nothing in this Option will be deemed to create in any way whatsoever any obligation on your part to continue in the service of the Company or any Affiliate, or on the part of the Company or any Affiliate to continue such service.&nbsp;&nbsp;In addition, nothing in this Option will obligate the Company or any Affiliate, their respective stockholders, boards of directors, Officers or Employees to continue any relationship that you might have as an Employee, Director or consultant for the Company or any Affiliate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">11.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Tax Withholding Obligations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">At the time you exercise this Option, in whole or in part, and at any time thereafter as requested by the Company, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a &#8220;cashless exercise&#8221; pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or any Affiliate which arise in connection with this Option.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Upon your request and subject to approval by the Board, in its sole discretion, and in compliance with any applicable legal conditions or restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon exercise of this Option a number of whole shares of Common Stock with a Fair Market Value on the date of exercise not in excess of the maximum amount of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of this Option as a liability for financial accounting purposes).</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">You may not exercise this Option unless the tax withholding obligations of the Company and/or any Affiliate are satisfied.&nbsp;&nbsp;Accordingly, you may not be able to exercise this Option when desired even though this Option is vested, and the Company will have no obligation to issue a certificate for any shares of Common Stock unless such obligations are satisfied.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">12.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Tax Consequences</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Company has no duty or obligation to minimize the tax consequences to you of this Option and will not be liable to you for any adverse tax consequences to you arising in connection with this Option.&nbsp;&nbsp;You acknowledge that this Option is exempt from Section 409A of the Code only if the exercise price per share set forth in the Grant Notice is at least equal to the &#8220;fair market value&#8221; per share of the Common Stock on the Date of Grant and there is no other impermissible deferral of compensation associated with the Option.&nbsp;&nbsp;You are hereby advised to consult with your own personal tax, financial and/or legal advisors regarding </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">4</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">the tax consequences of this Option and by accepting this Option, you have agreed that you have done so or knowingly and voluntarily declined to do so. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">13.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Other Documents.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;You hereby acknowledge receipt of or the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus.&nbsp;&nbsp;In addition, you acknowledge receipt of the Company&#8217;s policy permitting certain individuals to sell shares of Common Stock only during certain &#8220;window&#8221; periods in effect from time to time and the Company&#8217;s insider trading policy.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">14.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Notices.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Any notices provided for in this Agreement or the Plan will be given in writing (including electronically) and will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company.&nbsp;&nbsp;The Company may, in its sole discretion, decide to deliver any documents related to this Option or participation in the Plan by electronic means or to request your consent to participate in the Plan by electronic means.&nbsp;&nbsp;By accepting this Option, you consent to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">15.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Governing Plan Document.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;This Option is subject to all the provisions of the Plan, the provisions of which are hereby made a part of this Option, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan.&nbsp;&nbsp;Except as otherwise expressly provided in the Grant Notice or this Agreement, in the event of any conflict between the terms in the Grant Notice or this Agreement and the terms of the Plan, the terms of the Plan will control.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">16.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-family:Times New Roman Bold;font-variant: small-caps;color:#000000;">Stockholder Rights</font><font style="color:#000000;">. </font><font style="font-weight:normal;color:#000000;"> You will not have voting or any other rights as a stockholder of the Company with respect to the shares of Common Stock to be issued pursuant to this Option until such shares are issued to you.&nbsp;&nbsp;Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company.&nbsp;&nbsp;Nothing contained in this Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">17.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Severability.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;If any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid.&nbsp;&nbsp;Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">18.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Effect on Other Employee Benefit Plans.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The value of this Option will not be included as compensation, earnings, salaries, or other similar terms used when calculating your benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides.&nbsp;&nbsp;The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#8217;s or any Affiliate&#8217;s employee benefit plans.</font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">5</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">19.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-family:Times New Roman Bold;font-variant: small-caps;color:#000000;">Choice of Law</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The interpretation, performance and enforcement of this Agreement will be governed by the law of the state of Delaware without regard to such state&#8217;s conflicts of laws rules.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">20.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Amendment.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Any amendment to this Agreement must be in writing, signed by a duly authorized representative of the Company.&nbsp;&nbsp;Notwithstanding anything in the Plan to the contrary, the Board reserves the right to amend this Agreement in any way it may deem necessary or advisable to carry out the purpose of the grant as a result of any change in applicable laws or regulations or any future law, regulation, interpretation, ruling, or judicial decision.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">21.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Miscellaneous</font><font style="color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">The rights and obligations of the Company under this Option will be transferable to any one or more persons or entities, and all covenants and agreements hereunder will inure to the benefit of, and be enforceable by, the Company&#8217;s successors and assigns. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of this Option.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">You acknowledge and agree that you have reviewed this Option in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting this Option, and fully understand all provisions of this Option.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">d.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">This Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">e.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">All obligations of the Company under the Plan and this Agreement will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;margin-left:15.38%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*<font style="margin-left:36pt;">**</font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:15.38%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Option Agreement will be deemed to be accepted by you upon your acceptance of the Option Grant Notice to which it is attached.</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-size:14pt;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">6</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;text-transform:none;font-variant: small-caps;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;">Attachment II</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">2021 <font style="font-family:Times New Roman;">Inducement Award</font> Plan</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">2021 <font style="font-family:Times New Roman;">Inducement Award</font> Plan</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;text-transform:none;font-variant: small-caps;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-style:normal;">Restricted Stock Unit Award Grant Notice</p>
<p style="margin-bottom:0pt;text-align:center;margin-top:0pt;text-indent:0%;font-size:14pt;font-family:Times New Roman;font-weight:bold;text-transform:uppercase;">&nbsp;</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dynavax Technologies Corporation (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221;) hereby grants to Participant a Restricted Stock Unit Award (the &#8220;<font style="font-weight:bold;font-style:italic;">Award</font>&#8221;) under the Dynavax Technologies Corporation 2021 Inducement Award Plan (the &#8220;<font style="font-weight:bold;font-style:italic;">Plan</font>&#8221;) for the number of restricted stock units (the &#8220;<font style="font-weight:bold;font-style:italic;">RSUs</font>&#8221;) set forth below.&nbsp;&nbsp;This Award is subject to all of the terms and conditions set forth in this Restricted Stock Unit Award Grant Notice (the &#8220;<font style="font-weight:bold;font-style:italic;">Grant Notice</font>&#8221;) and in the Restricted Stock Unit Award Agreement (the &#8220;<font style="font-weight:bold;font-style:italic;">Agreement</font>&#8221;) and the Plan, both of which are attached hereto and incorporated herein in their entirety.&nbsp;&nbsp;Capitalized terms not explicitly defined in this Grant Notice but defined in the Plan or the Agreement will have the same definitions as in the Plan or the Agreement.</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Participant:<font style="margin-left:216pt;"></font><font style="text-decoration:underline;margin-left:396pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date of Grant:<font style="margin-left:216pt;"></font><font style="text-decoration:underline;margin-left:396pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vesting Commencement Date:<font style="margin-left:216pt;"></font><font style="text-decoration:underline;margin-left:396pt;"></font></p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of RSUs Subject to Award:<font style="margin-left:216pt;"></font><font style="text-decoration:underline;margin-left:396pt;"></font></p>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:19.23%;text-indent:-19.04%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:0.15%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td>
<td valign="top" style="width:19.08%;white-space:nowrap">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Vesting Schedule:</font><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </font></p></td>
<td valign="top">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:normal;">Subject to Section 2 of the Agreement, this Award will vest as follows: [_________].</font></p></td></tr></table></div>
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;margin-left:19.23%;text-indent:-19.04%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:19.23%;white-space:nowrap">
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Issuance Schedule:</font></p></td>
<td valign="top">
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><font style="font-weight:normal;">One share of Common Stock will be issued for each RSU that vests at the time set forth in Section 6 of the Agreement.</font></p></td></tr></table></div>
<p style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Additional Terms/Acknowledgements:<font style="font-weight:normal;">&nbsp;&nbsp;Participant acknowledges receipt of, and understands and agrees to, this Grant Notice, the Agreement and the Plan.&nbsp;&nbsp;Participant further acknowledges that as of the Date of Grant, this Grant Notice, the Agreement and the Plan set forth the entire understanding between Participant and the Company regarding this Award and supersede all prior oral and written agreements, promises and/or representations regarding this Award, with the exception of any written employment, offer letter or severance agreement, or any written severance plan or policy, in each case that specifies the terms that should govern this Award.&nbsp;&nbsp;By accepting this Award, Participant consents to receive this Grant Notice, the Agreement, the Plan, the prospectus for the Plan and any other Plan-related documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.&nbsp;&nbsp;Participant&#8217;s acceptance of this Award, and Participant&#8217;s acknowledgement and agreement with the terms set forth in this paragraph, will be evidenced by Participant&#8217;s signature below or by electronic acceptance or authentication in a form authorized by the Company.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:478.8pt;;">
<tr>
<td style="width:239.4pt;"></td>
<td style="width:239.4pt;"></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:<font style="text-decoration:underline;"></font></p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature</p>
<p style="margin-bottom:6pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Title:<font style="text-decoration:underline;"></font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:<font style="text-decoration:underline;"></font></p></td>
<td valign="top" >
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Participant</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p>
<p style="text-align:center;margin-bottom:6pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Signature</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date:<font style="text-decoration:underline;"></font></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:18.31%;text-indent:-18.31%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:18.27%;text-indent:-18.27%;font-weight:bold;font-size:10pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Attachments<font style="font-variant: normal;">:</font><font style="font-weight:normal;font-variant: normal;">&nbsp;&nbsp;Restricted Stock Unit Award Agreement and 2021 Inducement Award Plan</font></p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a>.</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Attachment I</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">2021 <font style="font-family:Times New Roman;">Inducement Award</font> Plan</p>
<p style="text-align:center;margin-bottom:24pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Restricted Stock Unit Award Agreement</p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the accompanying Restricted Stock Unit Award Grant Notice (the &#8220;<font style="font-weight:bold;font-style:italic;">Grant Notice</font>&#8221;) and this Restricted Stock Unit Award Agreement (the &#8220;<font style="font-weight:bold;font-style:italic;">Agreement</font>&#8221;), Dynavax Technologies Corporation (the &#8220;<font style="font-weight:bold;font-style:italic;">Company</font>&#8221;) has granted you a Restricted Stock Unit Award (the &#8220;<font style="font-weight:bold;font-style:italic;">Award</font>&#8221;) under the Dynavax Technologies Corporation 2021 Inducement Award Plan (the &#8220;<font style="font-weight:bold;font-style:italic;">Plan</font>&#8221;) for the number of restricted stock units (the &#8220;<font style="font-weight:bold;font-style:italic;">Restricted Stock Units</font>&#8221;) set forth in the Grant Notice.&nbsp;&nbsp;This Award is granted to you effective as of the date of grant set forth in the Grant Notice (the &#8220;<font style="font-weight:bold;font-style:italic;">Date of Grant</font>&#8221;).&nbsp;&nbsp;Capitalized terms not explicitly defined in this Agreement but defined in the Plan or the Grant Notice will have the same definitions as in the Plan or the Grant Notice.</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">22.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Grant of the Award.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">This Award represents your right to be issued on a future date (as set forth in Section 6) one share of Common Stock for each Restricted Stock Unit subject to this Award that vests in accordance with the Grant Notice and this Agreement.&nbsp;&nbsp;Except as otherwise provided herein, you will not be required to make any payment to the Company (other than services to the Company or an Affiliate) with respect to your receipt of the Award, the vesting of the Restricted Stock Units or the issuance of any shares of Common Stock in respect of this Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">23.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Vesting</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Subject to the limitations contained herein, this Award will vest, if at all, in accordance with the vesting schedule set forth in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service.&nbsp;&nbsp;Upon such termination of your Continuous Service, you will forfeit (at no cost to the Company) any Restricted Stock Units subject to this Award that have not vested as of the date of such termination and you will have no further right, title or interest in such Restricted Stock Units. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">24.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Number of Restricted Stock Units and Shares of Common Stock</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">The number of Restricted Stock Units subject to this Award, as set forth in the Grant Notice, will be adjusted for Capitalization Adjustments, if any, as provided in the Plan.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Any additional Restricted Stock Units and any shares of Common Stock, cash or other property that become subject to this Award pursuant to this Section 3 will be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of issuance as applicable to the other Restricted Stock Units subject to this Award to which they relate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">No fractional shares or rights for fractional shares of Common Stock will be created pursuant to this Section 3.&nbsp;&nbsp;Any fractional shares that may be created by the adjustments referred to in this Section 3 will be rounded down to the nearest whole share.</font></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</a>.</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">25.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Securities Law Compliance</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;You will not be issued any shares of Common Stock in respect of this Award unless either (i) such shares are registered under the Securities Act or (ii) the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act.&nbsp;&nbsp;This Award also must comply with all other applicable laws and regulations governing this Award, and you will not receive any shares of Common Stock in respect of this Award if the Company determines that such receipt would not be in material compliance with such laws and regulations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">26.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Transferability.&nbsp;&nbsp;</font><font style="font-weight:normal;color:#000000;">This Award is not transferable, except by will or by the laws of descent and distribution and prior to the time that shares of Common Stock in respect of this Award have been issued to you, you may not transfer, pledge, sell or otherwise dispose of any portion of the Restricted Stock Units or the shares of Common Stock in respect of this Award.&nbsp;&nbsp;For example, you may not use any shares of Common Stock that may be issued in respect of this Award as security for a loan, nor may you transfer, pledge, sell or otherwise dispose of such shares.&nbsp;&nbsp;This restriction on transfer will lapse upon issuance to you of the shares of Common Stock in respect of this Award. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">27.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Issuance of Shares.&nbsp;&nbsp; </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">The issuance of any shares of Common Stock in respect of this Award is (i) subject to satisfaction of the tax withholding obligations set forth in Section 10 and (ii) intended to comply with Treasury Regulations Section 1.409A-1(b)(4) and will be construed and administered in such a manner.&nbsp;&nbsp;The form of such issuance (</font><font style="font-style:italic;font-weight:normal;color:#000000;">e.g.</font><font style="font-weight:normal;color:#000000;">, a stock certificate or electronic entry evidencing such shares) will be determined by the Company.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">In the event one or more Restricted Stock Units subject to this Award vests, the Company will issue to you, on the applicable vesting date, one (1) share of Common Stock for each Restricted Stock Unit that vests on such date (and for purposes of this Agreement, such issuance date is referred to as the &#8220;</font><font style="font-style:italic;color:#000000;">Original Issuance Date</font><font style="font-weight:normal;color:#000000;">&#8221;); </font><font style="font-style:italic;font-weight:normal;color:#000000;">provided, however</font><font style="font-weight:normal;color:#000000;">, that if the Original Issuance Date falls on a date that is not a business day, such shares will instead be issued to you on the next following business day.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Notwithstanding the foregoing, </font><font style="text-decoration:underline;font-weight:normal;color:#000000;">if</font><font style="font-weight:normal;color:#000000;">: </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">1)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">this Award is otherwise subject to Withholding Taxes (as described in Section 10) on the Original Issuance Date,</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">2)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;"> the Original Issuance Date does not occur (x) during an &#8220;open window period&#8221; applicable to you, as determined by the Company in accordance with the Company&#8217;s then-effective policy on trading in Company securities, or (y) on a date when you are otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market, and </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:23.08%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">3)</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">the Company elects, prior to the Original Issuance Date, (x) not to satisfy such Withholding Taxes by withholding shares of Common Stock from the shares of Common Stock otherwise due, on the Original Issuance Date, to you under this Award, (y) not to permit you to enter into a &#8220;same day sale&#8221; commitment with a broker-dealer pursuant to Section 10 (including, but not limited to, under a previously established 10b5-1 trading plan entered into </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">2</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">in compliance with the Company&#8217;s policies),</font><font style="font-weight:normal;color:#000000;"> </font><font style="font-weight:normal;color:#000000;">and (z) not to permit you to pay such Withholding Taxes in cash, </font></p>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:15.38%;text-indent:-7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">then</font> the shares that would otherwise be issued to you on the Original Issuance Date will not be issued to you on the Original Issuance Date and will instead be issued to you on the first business day when you are not prohibited from selling shares of Common Stock on an established stock exchange or stock market, but in no event later than December 31 of the calendar year in which the Original Issuance Date occurs (that is, the last day of your taxable year in which the Original Issuance Date occurs), or, if permitted in a manner that complies with Treasury Regulations Section 1.409A-1(b)(4), no later than the date that is the 15th day of the third calendar month of the year following the year in which the shares of Common Stock in respect of this Award are no longer subject to a &#8220;substantial risk of forfeiture&#8221; within the meaning of Treasury Regulations Section 1.409A-1(d).</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">28.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Dividends.</font><font style="color:#000000;"> </font><font style="font-weight:normal;color:#000000;"> You will receive no benefit or adjustment to this Award with respect to any cash dividend, stock dividend or other distribution except as provided in the Plan with respect to a Capitalization Adjustment.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">29.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Restrictive Legends.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The shares of Common Stock issued in respect of this Award will be endorsed with appropriate legends, if any, as determined by the Company.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">30.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Award Not a Service Contract</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;This Award is not an employment or service contract, and nothing in this Award will be deemed to create in any way whatsoever any obligation on your part to continue in the service of the Company or any Affiliate, or on the part of the Company or any Affiliate to continue such service.&nbsp;&nbsp;In addition, nothing in this Award will obligate the Company or an Affiliate, their respective stockholders, boards of directors, Officers or Employees to continue any relationship that you might have as an Employee, Director or consultant for the Company or an Affiliate.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">31.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Tax Withholding Obligations.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><a name="OLE_LINK5"></a><a name="OLE_LINK6"></a><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">On or before the time you receive a distribution of any shares of Common Stock in respect of this Award, and at any other time as reasonably requested by the Company in accordance with applicable tax laws, you agree to make adequate provision for any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or any Affiliate that arise in connection with this Award (the &#8220;</font><font style="font-style:italic;color:#000000;">Withholding Taxes</font><font style="font-weight:normal;color:#000000;">&#8221;).&nbsp;&nbsp;Specifically, the Company or an Affiliate may, in its sole discretion, satisfy all or any portion of the Withholding Taxes relating to this Award by any of the following means or by a combination of such means: (i) withholding from any compensation otherwise payable to you by the Company or an Affiliate; (ii) causing you to tender a cash payment; (iii) permitting you to enter into a &#8220;same day sale&#8221; commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a &#8220;</font><font style="font-style:italic;color:#000000;">FINRA Dealer</font><font style="font-weight:normal;color:#000000;">&#8221;) whereby you irrevocably elect to sell a portion of the shares of Common Stock to be issued in connection with this Award to satisfy the Withholding Taxes and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Withholding Taxes directly to the Company and/or its Affiliates; or (iv) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to you in connection with this Award with a Fair Market Value (measured as of the date the shares of </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">3.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">Common Stock are issued to you) not in excess of the maximum amount of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of this Award as a liability for financial accounting purposes). </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">Unless the Withholding Taxes of the Company and/or any Affiliate are satisfied, the Company will have no obligation to issue to you any Common Stock.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">In the event the Company&#8217;s obligation to withhold arises prior to the issuance to you of Common Stock or it is determined after the issuance of Common Stock to you that the amount of the Company&#8217;s withholding obligation was greater than the amount withheld by the Company, you agree to indemnify and hold the Company harmless from any failure by the Company to withhold the proper amount.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">32.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Unsecured Obligation.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;This Award is unfunded, and as a holder of vested Restricted Stock Units, you will be considered an unsecured creditor of the Company with respect to the Company&#8217;s obligation, if any, to issue shares of Common Stock or other property pursuant to this Agreement.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">33.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-family:Times New Roman Bold;font-variant: small-caps;color:#000000;">Stockholder Rights</font><font style="color:#000000;">. </font><font style="font-weight:normal;color:#000000;"> You will not have voting or any other rights as a stockholder of the Company with respect to the shares of Common Stock to be issued pursuant to this Award until such shares are issued to you.&nbsp;&nbsp;Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company.&nbsp;&nbsp;Nothing contained in this Agreement, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">34.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Other Documents.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;You hereby acknowledge receipt of or the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus.&nbsp;&nbsp;In addition, you acknowledge receipt of the Company&#8217;s policy permitting certain individuals to sell shares of Common Stock only during certain &#8220;window&#8221; periods in effect from time to time and the Company&#8217;s insider trading policy.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">35.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Notices</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Any notices provided for in this Agreement or the Plan will be given in writing (including electronically) and will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company.&nbsp;&nbsp;The Company may, in its sole discretion, decide to deliver any documents related to this Award or participation in the Plan by electronic means or to request your consent to participate in the Plan by electronic means.&nbsp;&nbsp;By accepting this Award, you consent to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">36.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Governing Plan Document</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;This Award is subject to all the provisions of the Plan, the provisions of which are hereby made a part of this Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan.&nbsp;&nbsp;Except as otherwise expressly provided in the Grant Notice or this Agreement, in the event of any conflict between the terms in the Grant Notice or this Agreement and the terms of the Plan, the terms of the Plan will control. </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">4</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="text-decoration:none;Background-color:#auto;">37.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Severability.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;If any part of this Agreem</font><font style="font-weight:normal;color:#000000;">ent or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid.&nbsp;&nbsp;Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner which </font><font style="font-weight:normal;color:#000000;">will give effect to the terms of such Section or part of a Section to the fullest extent</font><font style="font-weight:normal;color:#000000;"> possible while remaining lawful and valid.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">38.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Effect on Other Employee Benefit Plans.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The value of this Award will not be included as compensation, earnings, salaries, or other similar terms used when calculating your benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides.&nbsp;&nbsp;The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#8217;s or any Affiliate&#8217;s employee benefit plans.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">39.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-family:Times New Roman Bold;font-variant: small-caps;color:#000000;">Choice of Law</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The interpretation, performance and enforcement of this Agreement will be governed by the law of the state of Delaware without regard to such state&#8217;s conflicts of laws rules.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">40.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Amendment.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;Any amendment to this Agreement must be in writing, signed by a duly authorized representative of the Company.&nbsp;&nbsp;Notwithstanding anything in the Plan to the contrary, the Board reserves the right to amend this Agreement in any way it may deem necessary or advisable to carry out the purpose of the grant as a result of any change in applicable laws or regulations or any future law, regulation, interpretation, ruling, or judicial decision. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">41.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Compliance with Section 409A of the Code</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;This Award is intended to comply with the &#8220;short-term deferral&#8221; rule set forth in Treasury Regulations Section 1.409A-1(b)(4).&nbsp;&nbsp;However, if (i) this Award fails to satisfy the requirements of the short-term deferral rule and is otherwise not exempt from, and therefore deemed to be deferred compensation subject to, Section 409A of the Code, (ii) you are deemed by the Company at the time of your &#8220;separation from service&#8221; (as such term is defined in Treasury Regulations Section 1.409A-1(h) without regard to any alternative definition thereunder) to be a &#8220;specified employee&#8221; for purposes of Section 409A(a)(2)(B)(i) of the Code, and (iii) any of the payments set forth herein are issuable upon such separation from service, then to the extent delayed commencement of any portion of such payments is required to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code and the related adverse taxation under Section 409A of the Code, such payments will not be provided to you prior to the earliest of (a) the date that is six (6) months and one (1) day after the date of such separation from service, (b) the date of your death, or (c) such earlier date as permitted under Section 409A of the Code without the imposition of adverse taxation.&nbsp;&nbsp;Upon the first business day following the expiration of such applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 20 will be paid in a lump sum to you, and any remaining payments due will be paid as otherwise provided herein.&nbsp;&nbsp;Each installment of Restricted Stock Units that vests under this Award is a &#8220;separate payment&#8221; for purposes of Treasury Regulations Section 1.409A-2(b)(2).</font><font style="font-variant: small-caps;color:#000000;"> </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">42.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Tax Consequences</font><font style="color:#000000;">.</font><font style="font-weight:normal;color:#000000;">&nbsp;&nbsp;The Company has no duty or obligation to minimize the tax consequences to you of this Award and will not be liable to you for any adverse tax consequences to you arising in connection with this Award.&nbsp;&nbsp;You are hereby advised to consult with your own personal tax, financial and/or legal advisors regarding the tax consequences of this Award and by </font></p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">5</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;color:#000000;">accepting this Award, you have agreed that you have done so or knowingly and voluntarily declined to do so.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:7.69%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">43.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-variant: small-caps;color:#000000;">Miscellaneous</font><font style="color:#000000;">.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">a.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">The rights and obligations of the Company under this Award will be transferable to any one or more persons or entities, and all covenants and agreements hereunder will inure to the benefit of, and be enforceable by, the Company&#8217;s successors and assigns. </font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">b.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of this Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">c.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">You acknowledge and agree that you have reviewed this Award in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting this Award, and fully understand all provisions of this Award.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">d.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">This Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.</font></p>
<p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:15.38%;font-weight:bold;font-style:normal;color:#000000;font-size:12pt;font-family:Times New Roman;text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="Background-color:#auto;text-decoration:none;">e.</font><font style="font-weight:normal;margin-left:36pt;color:#000000;"></font><font style="font-weight:normal;color:#000000;">All obligations of the Company under the Plan and this Agreement will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.</font></p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:7.69%;white-space:nowrap">
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</font></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:12pt;">**</p></td></tr></table></div>
<p style="margin-bottom:12pt;text-align:justify;margin-top:0pt;margin-left:15.38%;text-indent:7.69%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This Restricted Stock Unit Award Agreement will be deemed to be accepted by you upon your acceptance of the Restricted Stock Unit Award Grant Notice to which it is attached.</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;margin-top:12pt;line-height:10pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:7.69%;">6</a>.<font style="margin-left:36pt;"></font></p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-variant: small-caps;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;">Attachment II</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-variant: small-caps;font-family:Times New Roman;font-style:normal;text-transform:none;">Dynavax Technologies Corporation</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Times New Roman Bold;font-variant: small-caps;font-style:normal;text-transform:none;">2021 <font style="font-family:Times New Roman;">Inducement Award</font> Plan</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;">&nbsp;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="text-align:left;line-height:10pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>dvax-20210109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-01-12T18:10:07.2992593+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 77afbd2c82744bb680956a8b0d266e86 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:dvax="http://www.dynavax.com/20210109" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dynavax.com/20210109" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.dynavax.com/20210109/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dvax-20210109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dvax-20210109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>dvax-20210109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-01-12T18:10:07.2992593+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 77afbd2c82744bb680956a8b0d266e86 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>dvax-20210109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-01-12T18:10:07.2992593+00:00 -->
<!-- Version            : 5.0.1.571 -->
<!-- Package ID         : 77afbd2c82744bb680956a8b0d266e86 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dynavax.com/20210109/role/TemplateLink" xlink:href="dvax-20210109.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="dvax-20210109.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10490.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>dvax-8k_20210109_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dvax-20210109.xsd" xlink:type="simple"/>
    <context id="C_0001029142_20210109_20210109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001029142</identifier>
        </entity>
        <period>
            <startDate>2021-01-09</startDate>
            <endDate>2021-01-09</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001029142_20210109_20210109" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001029142_20210109_20210109" id="F_000004">0001029142</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001029142_20210109_20210109" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001029142_20210109_20210109" id="F_000002">2021-01-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001029142_20210109_20210109" id="F_000003">Dynavax Technologies Corporation</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="C_0001029142_20210109_20210109" id="F_000006">001-34207</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001029142_20210109_20210109" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001029142_20210109_20210109" id="F_000008">33-0728374</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001029142_20210109_20210109" id="F_000009">2100 Powell Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001029142_20210109_20210109" id="F_000010">Suite 900</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001029142_20210109_20210109" id="F_000011">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001029142_20210109_20210109" id="F_000012">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001029142_20210109_20210109" id="F_000013">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001029142_20210109_20210109" id="F_000014">(510)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001029142_20210109_20210109" id="F_000015">848-5100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001029142_20210109_20210109" id="F_000016">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001029142_20210109_20210109" id="F_000017">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001029142_20210109_20210109" id="F_000018">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001029142_20210109_20210109" id="F_000019">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001029142_20210109_20210109" id="F_000020">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001029142_20210109_20210109" id="F_000021">DVAX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001029142_20210109_20210109" id="F_000022">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001029142_20210109_20210109" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140357837666888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  09,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Dynavax Technologies Corporation<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001029142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0728374<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2100 Powell Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">848-5100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVAX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
M[3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]
M9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIX
MT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T
M_C6"R0_L?@!02P,$%     @  (,L4CJJHN=  0  / (   \   !X;"]W;W)K
M8F]O:RYX;6R-45UKPS ,_"O&/V!)RU98:09CW4=A;&4=?7=BI1&UK6"K[=9?
M/R4AK+"7/<DZB=/=>7&BN"^)]NK+NY *W3"W\RQ+50/>I"MJ(<BDIN@-2QMW
M66HC&)L: /8NF^;Y+/,&@[Y;C%SKF%TVQ% Q4A"P [8(I_0[[UIUQ(0E.N3O
M0O=O!UIY#.CQ#+;0N5:IH=,+13Q38.,V523G"CT9!EN(C-4?>-.)_#1EZA$V
MY8<1(86>Y4)88TS<;_3\1C0>09:'[L#TA(XA+@W#<Z1#BV'7T8B+[,)&G\-8
MAQ#G\3\Q4EUC!4NJ#AX"#SE&<)W D!ILDU;!>"CTN*+N@U6/@24DM0H#E>QV
M3N7TR@ZN6>1>9!CG*(.XLH/P4:V%&@/8-SF0!)?DJG547>EYIM<WDUM)Z.#<
M@V#OX96,'<V/'W?W U!+ P04    "   @RQ2)!Z;HJT   #X 0  &@   'AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K
M+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;
MM(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /
M,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G
M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @  (,L4F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
M8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#
ML9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/
MN]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DW
MY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "
M@RQ2!T%-8H$   "Q    $               @ $     9&]C4')O<',O87!P
M+GAM;%!+ 0(4 Q0    (  "#+%),H'\U[@   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  "#+%*97)PC$ 8
M )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @  (,L4K8E%TE5!   [Q   !@              ("!#0@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  "#+%*#J:4#U $
M #(&   -              "  9@,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  !P3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="dvax-8k_20210109.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="dvax-8k_20210109.htm">dvax-8k_20210109.htm</File>
    <File>dvax-20210109.xsd</File>
    <File>dvax-20210109_lab.xml</File>
    <File>dvax-20210109_pre.xml</File>
    <File>dvax-ex101_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dvax-8k_20210109.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dvax-8k_20210109.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dvax-20210109_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dvax-20210109_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dvax-20210109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "dvax",
   "nsuri": "http://www.dynavax.com/20210109",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "dvax-8k_20210109.htm",
      "contextRef": "C_0001029142_20210109_20210109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "role": "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "dvax-8k_20210109.htm",
      "contextRef": "C_0001029142_20210109_20210109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.dynavax.com/20210109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001564590-21-001001-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-001001-xbrl.zip
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M@.AW&:0@7((-&:H!)A-84:):4K,]#$FTU+90#9X6))^$'LJ ?C<6")&F\9S
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M+4&9Z=3>$6^UQ\SY@9L3" U#$<"2AO&.03 E ^8%M\A;6*BW"36*OY(A]U!
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MWB$472DC)O:B\1Y$H\R*%;S58AO12.H>DB=+]*RCN[:%3_IBJ^W"9HS=0B;
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M%2\!1$L%H2/!$C6<ZHJ-TG8$((4\%MA8OD%\DUV^T Y\=0:#4_2'QWS %;'
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MZ20IRBIP<U\G7)K>%=%> )FG&!E/0<.$!4J^KU8^I,U*FTXP"%,L0K^8.MJ
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MIZ2PDLKRE-,$VF\3W'&$XS"SP?2:43!)4@HL BN*0'8C*,75U0F([).+_)+
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MVPQ.BS3?T")9%JI /DE],V/;ZT\#L!)B8T-P">O$U\$&S@*57807S9(<5 /
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MCP'.'R' >:?X\;;QS3O.CV?4%V _3#E$Q97?!VRX;V)W==6W6G^'(BGR:UM
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M" R]ZT:ZN/5(#6#./(0?9_,J>$_)BDJ5^S@.'YAJU"4G/ ,/)CT6\1HS\Z5
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M=(W#U3>".+D*:T]--(7.#N6W<=QSV9OR>6+*SY/"9GJ"=_=6K6@H_[;-HIA
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MB^*KORG4ZL[%%IOT_ZZ[:\](PA^_J>)M\\>7^>U#+L#PP[GO21QBAMW_*(R
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M0=NXO&BY;TE IK408$NV &.JLEX5P<"HX^.@NUJ;C:]IO:36Q^(4PCXI\G1
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M9I@D2,I*"W<09T3L==)\QX,9"-<E:V#Y.ZAEV)&ECB9+75QBJA3C93DADPE
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MU.]AAO3';V9YO$;5\\U5M4SA+_\/4$L! A0#%     @  (,L4DGP0^VM!
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M:U\R,#(Q,#$P.2YH=&U02P$"% ,4    "   @RQ2-!%&KLRC  "''04 $
M            @ $7(P  9'9A>"UE>#$P,5\V+FAT;5!+!08     !0 % $4!
(   1QP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
